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Introduction 
            Described in the previous chapters is a method for quickly accessing differentially-
protected monosaccharides.1 This methodology could accelerate the synthesis of 
biologically active polysaccharides.  To examine this theory, we decided to employ this 
method to synthesize a chondroitin sulfate tetrasaccharide.   
            Chondroitin sulfate (CS) is a member of a class of linear, sulfated polysaccharides 
known as glycosaminoglycans (GAGs).  Glycosaminoglycans (GAGs) are comprised of 
repeating disaccharide subunits which alternate in uronic acid and aminosugar residues.  
These polysaccharides vary in stereochemistry, length, and patterns of sulfation.  GAGs are 
classified into two broad categories depending on the amino sugar present in the polymer.  
The glucosaminoglycans (hyaluronan, keratan sulfate, heparin, heparan sulfate) are based 
on D-glucosamine, while the galactosaminoglycans (chondroitin sulfate and dermatan 
sulfate) are based on D-galactosamine.  The uronic acid residue present in a CS 
disaccharide is glucuronic acid (GlcA), while either GlcA or iduronic acid (IdoA) can be 
present in heparan sulfate (HS), heparin, and dermatan sulfate (Figure 3.1). 2   
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Figure 3.1:  Glycosaminoglycans can be divided into two classes, glucosaminoglycans and 
galactosaminoglycans, based on the aminosugar residue present in the polysaccharide 
chain.  These classes are further divided based on the uronic acid or glycosyl residue 
present in the polysaccharide backbone and the sulfation pattern displayed along the chain.    
 
              CS is a heterogeneous, linear polysaccharide that can be found on the cell surface  
or in the extracellular matrix (Figure 3.2).  Its biosynthesis begins in the Golgi apparatus 
when a tetrasaccharide linker is attached to specific serine residues on certain proteins.  
Alternating units of GalNAc and GlcA are added, and then sulfotransferases sulfate 
specific hydroxyl groups along the oligosaccharide chain.  CS can be sulfated at any or all 
of the free hydroxyl groups, representing 256 different possible sulfation motifs for a 
simple tetrasaccharide.  Each sulfation pattern is denoted by a letter, such as CS-A (Figure 
3.1).2-3   
 
 
Figure 3.2:  Glycosaminoglycans can be found at the cell surface or in the extracellular 
matrix.   
 
 
            For years scientists have been interested in understanding the many roles that CS 
proteoglycans play in biology.    Monitoring mRNA levels of CS proteoglycans from both 
embryonic rat4a and chick4b brains at various stages of development has shown that CS 
proteoglycan expression is highly regulated in the developing brain.   Phenotypic studies 
 have also highlighted the importance of CS.   Mutations in 8 squashed vulva (sqv) genes 
have been shown to affect the biosynthesis of CS and heparan sulfate (HS) 
glycosaminoglycans in Caenorhabditis elegans, and these mutations are known to cause 
defects in cytokinesis and in vulval morphogenesis.  Further studies in Caenorhabditis 
elegans have confirmed that it the disruption of CS synthesis can lead to the observed 
phenotype. 5   Mutation of the chondroitin-4-sulfotransferase 1 gene in mice resulted in 
severe chondrodysplasia and a disorganized cartilage growth plate, and deletion of a 
chondroitin-6-sulfotransferase gene in humans causes severe skeletal defects.6  
Furthermore, altered expression of CS proteoglycans is common with a number of cancers 
including melanoma, pancreatic, ovarian, and gastric cancers and believed to stimulate 
cancer cell proliferation, migration, and invasion.7     
               CS has also been shown to regulate the development of the nervous system and 
has been assigned both stimulatory and inhibitory roles in neuronal growth and 
development.  CS has been shown to stimulate neurite outgrowth in rat hippocampal 
cultures,8 but CS proteoglycans have also been shown to repel migrating neurons.9   While 
suggesting the importance of sulfation in CS activity, these studies were unable to 
conclusively establish which sulfation pattern produces each biological response observed.   
            Many studies have attempted to explore this relationship with CSs isolated from 
natural sources.  Unfortunately, natural isolates, while enriched in a particular motif, still 
possess other sulfation motifs, so no clear relationships can be drawn between structure and 
function.  The use of synthetic CS tetrasaccharides with defined sulfation patterns has 
allowed examination of the role the sulfation pattern.   Studies performed in the Hsieh-
Wilson laboratory using synthetic chondroitin sulfate tetrasaccharides have confirmed that 
 the sulfation pattern determines the biological activity.  Four tetrasaccharides (CS-A, CS-C, 
CS-E, and CS-R) were synthesized and tested with hippocampal, dopaminergic, and dorsal 
root ganglion (DRG) neurons, and it was shown that only the CS-E tetrasaccharide 
stimulated neuronal growth.  These studies also established the tetrasaccharide as the 
minimum structure needed to produce a biological effect.10   
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            With these exciting results, it was desirable to expand the library of CS 
tetrasaccharides available to our laboratory.  We set out to design a single, differentially-
protected tetrasaccharide that would access all the desired sulfation patterns.   With this 
goal, we began to plan our synthetic strategy, examining carefully the knowledge gained 
from previous syntheses of CS.  
 
I.  Sinay’s Synthesis of a CS-A Disaccharide 
 
            Sinay and coworkers reported the synthesis of a CS-A disaccharide in 1989.  In 
their synthesis, glucosyl donor 1 and galactosamine acceptor 2 were joined via a silver 
triflate-mediated coupling to produce the β-(1,3)-linkage that forms CS disaccharide 3.  
The acetate protecting group present on the glucosyl 2-position served as a participating 
group to promote the formation of a β-(1,3)-linkage over the α-(1,3) linkage (Figure 3.3).  
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Figure 3.3:  Participating groups refer to protecting groups that can block one face of the 
donor, forcing the acceptor to attack the unhindered face.  Non-participating groups refer to 
protecting groups that do not perform in this manner.   
 
 
 Next, the benzylidene ring was selectively opened to produce the C-6 benzyl group, and 
the exposed C-4 position was sulfated.  Removal of the acetates and simultaneous 
saponification of the methyl ester produced disaccharide 4.  Simultaneous hydrogenolysis 
of the benzyl protecting group and reduction of the azide followed by acetate protection of 
the resulting amine produced the CS-A disaccharide (5, Scheme 3.1).  This synthesis 
established many reaction conditions that have become staples in CS synthesis.11   
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Scheme 3.1:  The synthesis of a CS-A disaccharide reported by Sinay and coworkers  
 
 
II.  Jacquinet’s Synthesis of CS-A and CS-C Disaccharides 
 
            A year later, Jacquinet and coworkers reported the synthesis of two CS-A and CS-C 
disaccharides.   They produced two disaccharides, one CS-A and the other CS-C, that 
contained the β-(1,3)-linkage and two that contained the β-(1,4)-linkage.  The formation of 
the β-(1,4)-linkage is notable for two reasons.  First, the C-4 position of the acceptor is 
known to be the least reactive position around the ring, and formation of the β-(1,4)-linkage 
can be complicated by this decrease in reactivity.   Second, the β-linkage was formed 
without the use of a participating group   To form CS-A and CS-C, galactosamine donors 6 
and 7 were generated from galactal and coupled to glucosyl acceptor 8.  The resulting 
disaccharides were subjected to TBAF to remove the primary TBS group to produce 
disaccharides 9 and 10.   The boron-mediated coupling was inspired by work from Schmidt 
and coworkers, who showed that α-trichloroacetimidates undergo inversion during low-
temperature, boron-mediated coupling reactions to afford β-(1,6)-, β-(1,4)-, and β-(1,3)-
 linkages with high levels of selectivity (β:α ratios from 4:1 ~ >19:1) without the use of a C-
2 participating group.12  
            To conclude the synthesis, disaccharides 9 and 10 were elaborated to the C-4 and C-
6 deprotected saccharides 11 and 12, respectively.  These disaccharides were sulfated 
before simultaneous hydrogenolysis of the benzyl groups and reduction of the azides.  The 
resulting amines were acetylated to produce CS-A and CS-C disaccharides 13 and 14 
(Scheme 3.2).13 
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Scheme 3.2:  Jacquinet’s synthesis of CS-A and CS-C disaccharides 
 
  
          
III.  Ogawa’s Synthesis of CS-A, CS-C, and CS-E Tetrasaccharides   
 
            The Ogawa laboratory has completed the synthesis of CS-A, CS-C, and CS-E 
tetrasaccharides.  As in the Jacquinet synthesis, monosaccharides 15 and 16 were coupled 
using Schmidt’s imidate methodology and then desilated to produce disaccharide 17.    This 
disaccharide was then elaborated to both donor 18 and acceptor 19, which were joined 
together via a second boron-mediated coupling to produce protected tetrasaccharide 20.  
The levulinoyl group on tetrasaccharide 20 was replaced with a more stable pivolate ester 
before the azide was reduced to the amine and acetylated to form tetrasaccharide 21 
(Scheme 3.3).    
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Scheme 3.3:  Ogawa’s synthesis of a core CS tetrasaccharide. 
 
            Tetrasaccharide 21 was elaborated to CS-A, CS-C, and CS-E through the following 
transformations:  To access the CS-E tetrasaccharide (22), the 4,6-benzylidene was 
removed, and the revealed positions were sulfated.  Finally, the remaining protecting 
groups were removed to afford the desired tetrasaccharide.  To access CS-A and CS-C, the 
benzylidene was selectively opened to reveal the C-4 position.  To produce the CS-A 
 tetrasaccharide (25), the C-4 hydroxyl was sulfated and then the remaining protecting 
groups were removed.  To access the CS-C tetrasaccharide, the C-4 hydroxyl of 
tetrasaccharide 23 was acetylated before subjecting it to hydrogenation to remove the C-6 
benzyl group.  The exposed position was sulfated, and the remaining protecting groups 
were removed to afford the CS-C tetrasaccharide (24, Scheme 3.4).14  
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Scheme 3.4:  Elaboration to CS-A, CS-C, and CS-E tetrasaccharides  
  
             This synthesis was noteworthy for a number of reasons:  This synthesis employs a 
divergent strategy, allowing access to 3 tetrasaccharides from a core disaccharide. 
Furthermore, it reaffirms the usefulness of trichloroacetimidate donors for coupling both 
mono- and disaccharides.  In addition, this synthesis proves that it is feasible to perform 
late-stage protecting group manipulation on a tetrasaccharide to access other sulfation 
patterns.   
            However, this synthesis also revealed issues to consider as we approached our 
synthetic design.  First, it illustrated the importance of choosing protecting groups that can 
withstand all reaction conditions between its application and removal.  Second, the Ogawa 
group reported difficulties separating some of the products in the synthesis, suggesting the 
need to explore a range of purification methods for our synthesis.  Finally, the ability of 
tetrasaccharide 21 to access other sulfation patterns was limited in part by the lack of 
differentiation between the glucosyl C-2 and C-3 position, highlighting an issue to focus on 
during the design of our synthesis.   
 
IV.  Jacquinet’s Synthesis of  CS-D Tetra- and Hexasaccharides 
 
           The Jacquinet laboratory has published the synthesis of both a CS-D tetra- and 
hexasaccharide.  Acceptor 27 was prepared from disaccharide 26 via TMSOTf-mediated 
methanolysis of the imidate.  The C-4 ester was selectively removed with thiourea to afford 
disaccharide 27.   This disaccharide was then joined with donor 26 via a TMSOTf-
promoted coupling, and the C-4 chloroacetate of the resulting tetrasaccharide was removed 
with thiourea to afford tetrasaccharide 28.  This tetrasaccharide was subjected to similar 
 coupling conditions with donor 26 and, after chloroacetate deprotection with thiourea, 
afforded hexasaccharide 29 (Scheme 3.5).   
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Scheme 3.5:  Jacquinet’s synthesis of the core tetra- and hexasaccharides 
 
            Both tetrasaccharide 28 and hexasaccharide 29 were elaborated through the 
following chemistry.   First, the C-4 hydroxyl was protected using p-methoxybenzyl 
(MPM) trichloroacetimidate.  Next, the N-trichloroacetyl group was converted to the 
natural N-acetyl group through exposure to AIBN and tributyltin hydride.  Saponification 
of the C-5 methyl ester and removal of the benzoyl groups afforded tetra- and 
hexasaccharides 30 and 31.  Sulfation of the revealed hydroxyls followed by 
hydrogenolysis of the benzyl and MPM groups produced CS-D tetra- and hexasaccharides 
32 and 33 (Scheme 3.6).15   This synthesis was most notable for differentiating between the 
glucosyl C-2 and C-3 positions.  Furthermore, Jacquinet’s observations concerning the 
 difficulty of sulfating the glucosyl C-2 hydroxyl allowed us to be aware of strong sulfation 
conditions that would be needed to affect this transformation.   
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Scheme 3.6:  Elaboration to the CS-D tetra- and hexasaccharides 
 
V.  Hsieh-Wilson’s synthesis of CS-A, CS-C, CS-E, and CS-R Tetrasaccharides 
            The greatest source of information came from our laboratory’s experience 
synthesizing a library of CS-A, CS-C, CS-E, and CS-R tetrasaccharides.  This synthesis 
converges at a core disaccharide and tetrasaccharide from which all four sulfation patterns 
are accessed.   A TMSOTf-mediated coupling of imidate donor 34 and galactosamine 
acceptor 35 afforded disaccharide 36.   Exposure of disaccharide 36 to the Grubbs second-
generation catalyst followed by hydrolysis of the resulting enol ether removed the anomeric 
allyl group.  The resulting disaccharide was elaborated to form trichloroacetimidate donor 
37.  Disaccharide 36 was elaborated to acceptor 38 through removal of the TBS ether 
(Scheme 3.7).   
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Scheme 3.7:  Synthesis of the donor and acceptor disaccharides   
 
 
           Donor 37 and acceptor 38 were joined via a TBSOTf-mediated coupling reaction to 
form tetrasaccharide 39.  This tetrasaccharide was elaborated to core tetrasaccharide 40 
through conversion of the N-trichloroacetyl groups to N-acetyl groups through the use of 
tributyltin hydride and AIBN, followed by removal of the p-methoxybenzylidene rings.  To 
access CS-A, the galactosamine C-6 hydroxyl positions were selectively benzoylated, and 
the C-4 hydroxyls were sulfated through exposure to SO3-TMA.  Removal of the TBS 
ether, saponification of the methyl esters, and cleavage of the ester protecting groups 
afforded CS-A tetrasaccharide 41.  To form CS-C tetrasaccharide 42, the galactosamine C-
6 hydroxyl positions were selectively sulfated, and the remaining protecting groups were 
removed as before.   Accessing the CS-E tetrasaccharide proceeded through a similar 
pathway.  Sulfation of the galactosamine C-4 and C-6 hydroxyls followed by removal of 
 the remaining protecting groups produced CS-E tetrasaccharide 43.   To access the CS-R 
tetrasaccharide, two benzylidene rings were installed to protect the C-4 and C-6 hydroxyls.  
Next, saponification of the methyl esters followed by removal of the benzoyl protecting 
groups revealed the glucosyl C-2 and C-3 hydroxyls for sulfation.  After sulfation, 
simultaneous removal of the TBS ether and the benzylidene rings afforded CS-R 
tetrasaccharide 44.10    
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Scheme 3.8:  The Hsieh-Wilson synthesis of CS-A, CS-C, CS-E, and CS-R 
tetrasaccharides. 
 
 
            Certain details of this synthesis were noted when we designed the second-
generation tetrasaccharide.  This synthesis reaffirmed the use of a core disaccharide to 
access multiple tetrasaccharides. It was also noted that the sulfation conditions used to 
produce CS-R tetrasaccharide 44 were found to be acidic enough to remove the p-
 methoxybenzylidene protecting groups, so acid-sensitive protecting groups should be used 
judiciously.  In addition, this synthesis provided conditions to selectively protect or sulfate 
the galactosamine C-6 position over the neighboring C-4 position.  In addition, a 
rearrangement was observed during the tetrasaccharide coupling (Figure 3.4), and it was 
hoped that substitution of the N-trichloroacetyl group for a more activating protecting 
group would minimize this rearrangement and improve coupling yields.16 The 
trichloroethyl carbamate had been shown to be a more active group in disaccharide 
couplings with no reported rearranged product, so this group was chosen as the amine 
protecting group for our synthesis.17   Finally, later work with these tetrasaccharides 
revealed that the allyl group can serve as a useful chemical handle, so it was decided that 
this functional group would remain but be installed later in the synthesis to avoid the two-
step deprotection necessary to remove it (Figure 3.5).10b, 16, 18  
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Figure 3.4:  Donor 37 can undergo rearrangement to amide 45.   
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Figure 3.5:  The allyl group can be used as a chemical handle for attaching tetrasaccharides 
to surfaces or other molecules.  
 
 
Retrosynthesis of the CS Disaccharide 
 The retrosynthetic analysis of our tetrasaccharide (51) begins by cleaving the β-
(1,4) linkage to produce disaccharides 49 and 50 that can both be accessed from a core 
disaccharide (48, Scheme 3.9).  A TIPS protecting group was chosen for the glucosyl C-4 
position on disaccharide 48 because this silyl ether can be selective cleaved using 
HF·pyridine or TBAF in the presence of many other protecting groups.  Furthermore, the 
TIPS group has been described as the most stable of the silyl protecting groups, making it 
likely that it will be able to withstand coupling and sulfation conditions.19  As mentioned 
before, it was hoped that the MacMillan sugar methodology (described in Chapters 1 and 2) 
could be used to accelerate this synthesis.  This methodology would allow access to a 
glucose monosaccharide that possessed TIPS groups at the C-6 and C-4 hydroxyl groups.  
The primary TIPS group can be selectively removed for oxidation of the C-5 position.1c   
This would occur before removal of the C-4 TIPS ether was necessary, so this protecting 
group scheme was acceptable.  A number of groups were considered for the C-2 and C-3 
glucosyl positions.  For the C-2 hydroxyl group, it was important to choose a participating 
 group (Figure 3.3) which would allow access to the β-(1,3)-linkage found in CS.  Initially, 
a levulinoyl (Lev) group was chosen for the C-2 position because it can be selectively 
removed with sodium borohydride,20 but this was abandoned when evidence of Lev-group 
migration was found.  It was then decided that an acetate group may be a better choice for 
the C-2 hydroxyl.  Benzoyl esters were chosen to protect the glucosyl C-1 and C-3 
hydroxyls for two reasons.  First, the acetyl protecting groups can be selectively removed in 
the presence of benzoyl group through the use of hydrazine or guanidine, allowing 
differentiation between the C-2 and C-3 position.2b, 20  Second, an anomeric benzoyl group 
can be directly activated to form a thioglycoside.21   
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Scheme 3.9:  Retrosynthetic analysis of the core disaccharide  
 
   Next, the protecting groups for the galactosamine residue were determined.  An 
anomeric acetate group was chosen for the disaccharide because it is highly precedented in 
carbohydrate chemistry as a group that is stable to coupling reactions and can be removed 
selectively for coupling.2b, 20  A trichloroethylcarbamate (Troc) protecting group was 
selected to protect the amine for reasons described above.17  A benzyl group was chosen for 
the galactosamine C-4 hydroxyl group because it can be selectively removed in the 
presence of the ester and silyl protecting groups.20  Furthermore, evidence suggested that it 
could be removed without reduction of the allyl group at the galactosamine anomeric 
position.22  The allyl group at the anomeric position was chosen because it can be converted 
via ozonolysis to the aldehyde, which can serve as a chemical handle for the attachment to 
surfaces.10b, 16, 18  Finally, an acetate group was selected for the galactosamine C-6 position 
because the removal of a primary acetate group in the presence of a secondary acetate is 
precedented in carbohydrate chemistry.2b   
 This disaccharide could come from the coupling of monosaccharides 46 and 47 
(Scheme 3.9).  To quickly access the desired monosaccharides, two methodologies would 
be employed—the two-step sugar methodology developed by the MacMillan laboratory1 
and a Cerny epoxide methodology developed in the Hsieh-Wilson laboratory.23  Briefly, 
the MacMillan methodology allows differentiation of the C-2 and C-3 hydroxyl groups by 
assembling the monosaccharide through two aldol reactions of three protected α-
oxyaldehydes.    The Hsieh-Wilson methodology provides an efficient way to access 
aminosugars through the use of Cerny epoxides.  Cerny epoxides are known to isomerize 
under basic conditions, but through simultaneous epoxide formation and C-4 hydroxyl 
 protection, the Hsieh-Wilson methodology traps the desired kinetic epoxide.  This epoxide 
can be opened to provide a 3-hydroxyhexose ready for coupling (Figure 3.6).   
SPh
OTIPSO
BzO
OAc
O
BnO
HO
NHTroc
OAc
OAc
O
O
HO
OH
I
O
O
BnO O
H
OTIPS
O
OTIPS
OHTMSO
OAc +
OTIPS
BnBr, NaH
DMF
Nuc: O
O
Bn
OH
Nuc
MgBr2•Et2O
Et2O
OH
OTIPSO
HO
OAc
OTIPS
46
47
52 53 54
55 56 57
(a)
(b)
 
Figure 3.6:  (a) Glucosyl monomer 46 can be accessed using an aldol methodology.  (b) 
Galactosamine monomer 47 can be accessed through a Cerny epoxide.  
 
   Monosaccharides 46 and 47 were chosen as the coupling partners.  It was initially 
decided that the glucosyl C-5 methyl ester would be formed after synthesizing core 
disaccharide 48 because C-5 esters have been shown to deactivate the donor in coupling 
reactions.2b   Opening the 1,6-anhydro ring on the galactosamine monomer after the 
coupling would eliminate two steps (protection and deprotection of the galactosamine C-3 
hydroxyl group) from the synthesis, so this pathway was chosen.  
  
 
Synthesis of the CS Disaccharide 
 In the forward sense, we began by synthesizing the glucose and galactosamine 
monomers.  The synthesis of the glucose monomer proceeded as follows:  First, cis-butene 
diol 58 was protected with TIPS-Cl and ozonolyzed to create the TIPS-aldehyde (59).  This 
aldehyde was dimerized via a proline-catalyzed aldol reaction to produce TIPS-erythrose 
60.  Acetoxyenolate 62 was also synthesized from butane diol.  Diol 58 was acetate 
protected and ozonlyzed to produce acetoxyaldehyde 61.24  This aldehyde was enolized 
with TMS-Cl and triethylamine to afford enolate 62.  The TIPS-erythrose and enolate 62 
were combined in a MgBr2•OEt2-mediated aldol reaction to produce glucose 63.1  Efforts 
were made to protect the anomeric and C-3 hydroxyls in one step, but migration of the C-2 
acetate to the anomeric position occurred in conditions basic enough to protect the C-3 
position.  Reducing the basicity to avoid migration prevented protection of the C-3 
hydroxyl group.  In the end, a two-step method was used where the anomeric position was 
protected using mildly basic conditions, and then more basic reaction conditions were used 
to protect the C-3 hydroxyl group.  Finally, the anomeric position was activated with ZnI2 
to afford thioglycoside 64 (Scheme 3.10).    
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Scheme 3.10:  Synthesis of glucosyl donor 64 
 
 The galactosamine monomer synthesis begins with peracetylated galactose 65.  
Bromination of the anomeric position followed by a zinc-mediated elimination produced 
tri-O-acetyl galactal, which was deprotected with sodium methoxide in methanol to 
produce galactal (66).25  Galactal was then subjected to a two-step iodo-cyclization reaction 
to provide iodogalactal 67.26  The iodogalactal was simultaneously benzyl-protected at the 
C-4 position and epoxidized to form epoxide 68.23  The epoxide was opened with 
ammonia27  and the resulting amine was Troc-protected to afford galactosamine 69 
(Scheme 3.11).  
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Scheme 3.11:  Synthesis of galactosamine acceptor 69 
 
 Glucosyl donor 64 and galactosamine acceptor 67 were combined via a TMSOTf-
mediated coupling to provide disaccharide 70 in 62% yield.  Investigations of this reaction 
revealed that the primary TIPS group was unstable to the coupling conditions, permitting 
an intramolecular cyclization to produce 1,6-anhydro glucose 71.   It was then decided to 
install the C-5 methyl ester before coupling, because this would prevent the formation of 
the 1,6-anhydro glucose byproduct (Scheme 3.12).   
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Scheme 3.12:  Formation of disaccharide 70 
  
 To that end, the primary TIPS group was removed on glucosyl donor 64 with 
HF·pyridine to produce glucose 72.  The C-6 hydroxyl was subjected to a TEMPO-
oxidation to form the acid, which was converted to the methyl ester through treatment with 
diazomethane.  This new glucosyl donor (73) was subjected to similar coupling conditions 
with galactosamine 69 to afford disaccharide 74 in 53% yield.  Attempts to open the 1,6-
anhydro ring of disaccharide 74 with acetic anhydride and TMSOTf  produced widely 
variable yields due to cleavage of the glycosidic bond to produce monosaccharides 76 and 
77.  Because of this, it was decided that the 1,6-anhydro ring would be opened prior to 
coupling (Scheme 3.13).  
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 Scheme 3.13:  Synthesis of glucosyl donor 73 allowed formation of disaccharide 74, but 
attempts to open the 1,6-anhydro ring produced the desired disaccharide 75 variable yields.  
 
 To open the 1,6-anhydro ring, galactosamine 69 was first protected at the C-3 
hydroxyl group with a levulinoyl ester.  Exposure to acetic anhydride and catalytic 
TMSOTf opened the 1,6-anhydro ring, and then the Lev group was removed with sodium 
borohydride.  This new galactosamine acceptor (78) was combined with glucosyl donor 73 
in a TMSOTf-mediated coupling reaction to produce disaccharide 75.  The anomeric 
acetate group was removed with benzylamine in THF, and the anomeric position was 
activated to the imidate.  The imidate was then coupled to allyl alcohol to produce allyl 
disaccharide 79.   
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Scheme 3.14:  Synthesis of core disaccharide 79   
 
 Conclusions 
 Synthesis of CS polysaccharides with defined length and pattern of sulfation has 
been achieved by many groups, and the use of synthetic saccharides provides a great 
opportunity to probe the role of sulfation in CS biological activity.  Described above is the 
design and synthesis of a core CS disaccharide that can access a wide range of CS sulfation 
motifs.  Glucosyl donor 73 has been accessed in 13 steps through the use of the MacMillan 
sugar methodology. A methodology developed in the Hsieh-Wilson laboratory was used to 
access galactosamine acceptor 76 in 11 steps.  These monosaccharides were coupled to 
produce core disaccharide 79.   
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General Methods 
 
Unless stated otherwise, reactions were performed in oven-dried  glassware that had 
been cooled in a desiccator over Dririte.  Reactions were performed under an argon 
environment unless otherwise stated.  All solvents were purified using the method of 
Grubbs.28 Unless stated otherwise, all commercially obtained reagents were used as 
received. Chemicals that were purified after purchase were purified according to the 
guidelines provided by Perrin and Armarego.29 Organic solutions were concentrated under 
reduced pressure on a Büchi rotary evaporator using an ice-water bath for volatile samples.  
High-performance liquid chromatography (HPLC) was performed on Hewlett-Packard 
 1100 Series chromatographs using a Chiralcel OD-H column (25 cm) and OD-H guard (5 
cm) as noted.  Liquid chromatography mass spectrometry analysis was performed on an 
Aglient 1100 series LCMS with an acetonitrile/water mobile phase treated with 0.1% acetic 
acid with a quadrapole detector. Thin-layer chromatography (TLC) was performed using E. 
Merck silica gel 60 F254 precoated plates (0.25 mm). Visualization of the developed 
chromatogram was performed by fluorescence quenching, cerium ammonium molybdate 
stain,  p-anisaldehyde, potassium permanganate stain, or ninhydrin stain as necessary. Flash 
chromatography was performed on ICN silica gel (particle size 0.032 - 0.063 mm) using 
the method of Still.30  
1H NMR and proton decoupling spectra were recorded on a Varian Mercury 300 
(300 MHz) or a Varian Inova 500 (500 MHz) and the 1H NMR spectra are reported in parts 
per million (δ) relative to the residual solvent peak. Data for 1H are reported as follows: 
chemical shift (δ, ppm), multiplicity (s = singlet, bs = broad singlet, d = doublet, t = triplet, 
q = quartet, m = multiplet), coupling constant(s) in Hz, and integration. 13C NMR spectra 
were obtained on a Varian Mercury 300 (75 MHz) spectrometer and 500 (125 MHz) 
spectrometer and are reported in parts per million (δ) relative to the residual solvent peak. 
IR spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in 
terms of frequency of absorption (cm-1). A JASCO P-1010 instrument was used to measure 
optical rotation. Mass spectra obtained from the Protein/Peptide MicroAnalytical 
Laboratory were generated on a Perkin Elmer/Sciex API 365 triple quadrapole mass 
spectrometer with nano spray ion source. Samples were dissolved in 50/50 MeOH/CH2Cl2, 
and infused at 0.2 microliter per minute.  High-resolution mass spectrometry was 
performed at the Mass Spectrometry Facility at the California Institute of Technology on 
 either a JEOL JMS-600H High Resolution Mass Spectrometer or a UPLC-LCT Premier 
XT TOF Mass Spectrometer using Leu-Enkephalin as lock mass in order to obtain exact 
mass.  The UPLC-LCT Premier XT was purchased in 2006 with a grant from the National 
Science Foundation Chemistry Research Instrumentation and Facilities Program (CHE-
0541745). 
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(2) Compound 11 (1.0 g, 1.9 mmol) was dissolved in dichloromethane (20 mL) in an oven-
dried round bottom flask and cooled to 0 °C.  To this solution was added freshly distilled 
benzoyl chloride (1.1 mL, 9.4 mmol), pyridine (0.3 mL, 1.0 mmol), and 
dimethylaminopyridine (45 mg, 0.4 mmol), and the reaction was allowed to warm to room 
temperature.  The reaction was stirred for 16 hours when it was quenched by the addition of 
dichloromethane (50 mL) and poured into an extraction funnel.  The organic layer was 
washed with saturated aqueous ammonium chloride (25 mL), saturated aqueous sodium 
bicarbonate (25 mL), and brine (25 mL).  The organic layer was dried over sodium sulfate, 
filtered, and concentrated via rotary evaporation.  The residue was purified by flash 
chromatography (20% EtOAc/Hexane) to afford compound 2, as a waxy solid in 82% 
yield.  (Rf = 0.4, 1:1 Et2O/Hexane) IR (film, CDCl3) 3533, 2944, 2892, 2866, 2866, 1790, 
1740, 1600, 1464, 1452, 1269, 1091, 1065  1H NMR (300 MHz, CDCl3): δ = 8.05 (m, 2H) 
ArH, 7.65-7.40 (m, 3H) ArH, 5.93 (d, 1H, J = 8.4 Hz) H-1, 5.13 (dd, 1H, J = 8.7, 8.1 Hz) 
 H-2, 4.08-3.92 (m, 4H), 3.78 (dd, 1H, J = 8.7, 8.4 Hz) H-4, 3.54 (ddd, 1H, J = 8.7, 3.3, 3.3) 
H-5, 2.07 (s, 3H) C(O)CH3, 1.15-0.84 (m, 42H) CH(CH3)2.  13C NMR (75 MHz, CDCl3):  
δ = 170.8, 164.9,133.5, 130.0, 129.4, 129.1, 92.4, 78.6, 76.3, 73.4, 71.4, 62.1, 20.9, 18.3, 
18.3, 17.8, 17.7, 13.0, 12.0. HRMS (ES+) exact mass calcd for [M+Na] requires m/z 
661.3568, found m/z 661.3567.  [α]D = +5.0,  (c = 1.00, CHCl3). 
 
(3)  In an oven-dried flask, compound 2 (1.19g, 1.86 mmol) was dissolved in pyridine (25 
mL) and cooled to 0 °C.  Dimethylaminopyridine (16 mg, 0.1 mmol) and benzoyl cyanide 
(1.32 g, 10.1 mmol) were added and the reaction was allowed to warm to room 
temperature.  The reaction was stirred overnight.  The reaction was concentrated via rotary 
evaporation and the residue was purified via flash chromatography (10% EtOAc/Hexane) 
to afford compound 3 as a waxy solid (1.20 g, 1.62 mmol, Rf = 0.5 in 1:1 Et2O/Hexane) in 
87% yield.  IR (film, CDCl3) 2944, 2892, 2867, 1739, 1464, 1452, 1262, 1091, 1069 1H 
NMR (500 MHz, CDCl3): δ = 8.05 (m, 4H) ArH, 7.60-7.43 (m, 6H) ArH, 6.08 (d, 1H, J = 
7.5 Hz) H-1, 5.50 (dd, 1H, J = 9.0, 9.0 Hz) H-3, 5.31 (dd, 1H, J = 8.0, 7.5 Hz), H-2, 4.35 
(dd, 1H, J = 8.5, 8.5 Hz) H-4, 4.02 (m, 2H) CH2, 3.68 (m, 1H) H-5, 1.88 (s, 3H) C(O)CH3, 
1.17-0.96 CH(CH3)2.  13C NMR (125 MHz, CDCl3):  δ = 169.7, 165.7, 164.7, 133.6, 133.3, 
132.9, 130.2, 129.7, 129.5, 129.0, 128.3, 92.1, 78.5, 76.4, 71.3, 68.6, 61.8, 20.6, 18.1, 18.1, 
17.9, 17.7, 13.2, 12.0.  HRMS (FAB) exact mass calcd. for [M+Na]+ (C40H62O9Si2Na) 
requires m/z 765.3825, found m/z 765.3825. [α]D = +6.3,  (c = 2.00, CHCl3). 
 
 
 (4)  To a flame-dried flask at 0 °C charged with zinc iodide (1.42 g, 4.4 mmol) and 
dichloromethane (50 mL) was added compound 3 (6.3 g, 8.5 mmol) as a solution in 
dichloromethane (20 mL).  Trimethylsilyl thiophenol (2.4 mL, 12.7 mmol) was added, and 
the reaction was allowed to stir for 10 hours.  The reaction was diluted with 
dichloromethane (70 mL) and poured into an extraction funnel.  The organic layer was 
washed with saturated aqueous ammonium chloride (70 mL), a saturated aqueous 
bicarbonate solution (70 mL), and brine (70 mL), and the organic layer was dried over 
sodium sulfate, filtered, and concentrated via rotary evaporation.  The residue was purified 
via flash chromatography (column 1: 10-20% EtOAc/Hexane, column 2: 30-60% 
Toluene/Hexane) to afford compound 4 as a waxy solid (5.2 g, 7.1 mmol, Rf = 0.55 in 1:1 
Et2O/Hexane) in 83% yield.  IR (film, CDCl3) 3062, 2944, 2891, 2867, 1753, 1730, 1464, 
1452, 1440, 1268, 1224, 1155, 1111, 1087, 1068, 1050, 1026, 883  1H NMR (300 MHz, 
CDCl3): δ = 8.01 (m, 2H) Ar-H, 7.61-7.24 (m, 8H) Ar-H, 5.41 (dd, 1H, J = 8.7, 8.7 Hz) H-
3, 5.05 (dd, 1H, J = 9.9, 9.3 Hz) H-2, 4.92 (d, 1H, J = 10.2 Hz) H-1, 4.10 (m, 2H) CH2, 
3.92 (dd, 1H, J = 10.8, 5.4 Hz) H-4, 3.52 (m, 1H) H-5, 1.92 (s, 3H) C(O)CH3, 1.09 (m, 
21H) CH(CH3)2, 0.95 (m, 21H) CH(CH3)2.  13C NMR (125 MHz, CDCl3):  δ = 170.0, 
166.0, 134.3, 134.5, 131.5, 130.0, 129.8, 129.1, 128.6, 127.6, 86.4, 82.4, 77.9, 71.3, 69.9, 
63.2, 21.0, 18.3, 18.3, 18.2, 18.2, 13.6, 12.2.  HRMS (FAB+) exact mass calcd. for 
[(M+H)-H2] (C39H61O7Si2) requires m/z 729.3677, found m/z 729.3698. [α]D = +21.2,  (c = 
1.00, CHCl3). 
 
 
 (5)  In a polypropylene flask equipped with a stir bar, compound 4 (3.5 g, 4.8 mmol) in 
THF (108 mL) was cooled to 0 °C.  Pyridine (78 mL) and water (25 mL) were added to the 
reaction solution.  In a separate polypropylene flask, pyridine (30 mL) was cooled to 0 °C, 
and a solution of hydrogen fluoride in pyridine (70% HF in 30% pyridine, 30 mL) was 
slowly and carefully added.  Dissolving the hydrogen fluoride into the pyridine produced 
an exotherm that was allowed to cool before proceeding.  Once the hydrogen fluoride 
solution cooled, it was added dropwise over 10 minutes to flask containing compound 4.  
The reaction was sealed and allowed to stir at 0 °C for 19 hours.  The reaction was 
carefully poured into an Erlenmeyer flask containing saturated aqueous sodium bicarbonate 
(250 mL) and ethyl acetate (100 mL) at 0 °C to quench the hydrogen fluoride before 
pouring the solution into an extraction funnel.  The organic layer was washed with 
saturated aqueous sodium bicarbonate (3x100 mL) and brine (100 mL) before being dried 
over sodium sulfate, filtered, and concentrated via rotary evaporation.  The residue was 
purified via flash chromatography (20% EtOAc/Hexane, Rf = 0.6 in 30% EtOAc/Hexane) 
to afford compound 5 (2.2 g, 3.8 mmol) in 78% yield as clear, colorless oil.  (Rf = 0.4 in 1:1 
Et2O/Hexane).  IR (film, CDCl3) 3505, 3061, 2994, 2891, 2867, 1749, 1730, 1269, 1223, 
1109, 1090, 1069, 1050, 1026, 883  1H NMR (300 MHz, CDCl3): δ = 7.85 (m, 2H) Ar-H, 
7.61-7.24 (m, 8H) Ar-H, 5.42 (dd, 1H) H-3, 5.04 (dd, 1H) H-2, 4.91 (d, 1H) H-1, 4.10 (dd, 
1H) H-4, 3.96 (ddd, 1H) H-5, 3.79 (m, 1H) H-6, 3.54 (m, 1H) H-6, 1.96 (dd, 1H) OH, 1.93 
(s, 3H) C(O)CH3, 0.98-0.86 (m, 21H) CH(CH3)2.  HRMS (FAB+) exact mass calcd. for 
[M+H]+ (C30H43O7SSi) requires m/z 575.2499, found m/z 597.2496. [α]D = +6.8,  (c = 1.00, 
CHCl3). 
 
  
(6)  Compound 5 (3.5 g, 6.0 mmol) was dissolved in dichloromethane (40 mL), and to this 
solution was added water (20 mL), TEMPO (191 mg, 1.2 mmol), and iodobenzene 
diacetate (4.9 g, 15.2 mmol).  The reaction was stirred for 3 hours before being quenched 
by the addition of dichloromethane (40 mL).  The reaction mixture was poured into an 
extraction funnel containing saturated aqueous sodium thiosulfate (40 mL).  The aqueous 
layer was extracted with dichloromethane (2x15 mL) and the combined organics were 
dried over sodium sulfate, filtered, and cooled to 0 °C.  Diazomethane in diethyl ether was 
added dropwise to the dichloromethane solution until TLC showed that all the acid (Rf = 
0.2 in 60% Et2O/Hexane) was consumed.  The reaction was stirred for 30 minutes before 
being allowed to warm to room temperature over an hour.  The reaction was quenched by 
the addition of acetic acid in toluene (0.5 mL in 10 mL, dropwise until bubbling ceases), 
and the solvent was removed via rotary evaporation.  The residue was purified by flash 
chromatography (10% EtOAc/Hexane) to afford compound 6 (2.2 g, 3.7 mmol) in 62% 
yield as a hard, slightly beige solid (Rf = 0.5 in 60% Et2O/Hexane).  1H NMR (300 MHz, 
CDCl3): δ = 7.98-7.30 (m, 10H) Ar-H, Ar-H, 5.41 (dd, 1H, J = 8.7, 8.1 Hz) H-2, 5.08 (dd, 
5.1, 3.6 Hz) H-3, 4.95 (d, 1H, J = 10.2 Hz) H-1, 4.44 (dd, 1H, J = 8.4, 8.4 Hz) H-4, 4.09 (d, 
1H, J = 8.4 Hz) H-5, 3.72 (s, 3H) CO2CH3, 1.96 (s, 3H) C(O)CH3, 0.96 (m, 21H) 
CH(CH3)2.  13C NMR (75 MHz, CDCl3):  δ = 169.4, 168.1, 165.6, 133.3, 132.4, 129.7, 
129.4, 129.0, 128.4, 128.1, 86.3, 80.1, 76.4, 70.6, 70.4, 29.7, 20.7, 17.9, 17.8, 13.0.  HRMS 
(ES+) exact mass calcd. for [M+Na]+ (C31H42O8SSiNa) requires m/z 625.2267, found m/z 
625.2265 [α]D = +7.3,  (c = 1.00, CHCl3). 
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(8)  Compound 723 (650 mg, 2.78 mmol) was dissolved in ethanol (13 mL) in a Schlenk flask and 
cooled to 0 °C.  Ammonia was bubbled through the ethanolic solution for 30 minutes.  The flask 
was immediately sealed, placed behind a blast shield, and heated to 110 °C while stirring for 24 
hours.   The reaction was cooled to room temperature and concentrated via rotary evaporation and 
a conversion of 69% was obtained by determining the molar 1H NMR ratio of two peaks, δ 5.48 (s) 
to δ 5.63 (d).  This method of determining yield assumes only two products to be present, the free 
amine and the starting epoxide. The crude mixture containing the free amine (352 mg, 1.40 mmol) 
and the starting epoxide were dissolved in THF (1.0 mL) and cooled to 0 °C.  In a vial, a 1N 
aqueous sodium bicarbonate solution (2.4 mL) and a 1N aqueous hydrochloric acid solution (1.0 
mL) were combined and added to the reaction mixture.  Then 2,2,2-trichloroethylchloroformate 
(208 μL, 1.54 mmol) was added slowly, and the reaction was allowed to warm to room 
temperature.  The reaction stirred for 4 hours, and was quenched by the addition of 
dichloromethane (10 mL).  The reaction was poured into an extraction funnel and the aqueous 
layer was extracted with dichloromethane (3x10 mL).  The organics were combined and washed 
 with brine (10 mL), dried over sodium sulfate, filtered, and the solvent was removed via rotary 
evaporation.  The residue was purified via flash chromatography (30 % EtOAc/Hexane) to afford 
compound 16 (508 mg, 1.2 mmol) in 85% yield as a white solid. (Rf = 0.35 in 50% 
EtOAc/Hexane). IR (film, CDCl3) 3430, 3307, 3033, 2954, 2899, 2360, 1736, 1531, 1235, 1135, 
1095, 1032, 932  1H NMR (300 MHz, CDCl3): δ = 7.38 (m, 5H) ArH, 5.38 (s, 1H) NH, 5.16 (d, 
1H, J = 9.3 Hz) H-1, 4.77-4.61 (m, 4H) CH2Ph, CH2CCl3, 4.41 (m, 2H) H-4, H-5, 4.04 (m, 2H) H-
3, H-6, 3.69 (m, 2H) H-2, H-6, 2.70 (broad s, 1H) OH.  13C NMR (75 MHz, CDCl3):  δ = 153.6, 
137.1, 128.8, 128.4, 127.8, 100.6, 95.3, 74.7, 72.6, 71.6, 71.6, 68.8, 64.8, 54.7.  HRMS (FAB+) 
exact mass calcd. for [M+H]+ ((C16H19O6NCl3) requires m/z 426.0278, found m/z 426.0290. [α]D = 
-24.0,  (c = 2.00, CHCl3). 
 
 
(9)  To a solution of 8 (258 mg, 0.6 mmol) in dichloromethane (7 mL) at 0 °C was added 
levulinic acid (0.13 mL, 1.3 mmol), dimethylaminopyridine (10 mg, 0.8 mmol), and 
dicyclohexylcarbodiimide (261 mg, 1.3 mmol).  The reaction was allowed to warm to room 
temperature and stir for 6 hours.  The reaction was quenched by dilution with 
dichloromethane (20 mL), and the organic layer was washed with water (5 mL) and brine 
(5 mL).  The organic layer was dried over sodium sulfate, filtered, and the solvent was 
removed via rotary evaporation.  The residue was purified via flash chromatography (50% 
EtOAc/Hexane) to afford compound 9 (286 mg, 0.54 mmol) in 90% yield as a white solid.  
(Rf = 0.3 in 50% EtOAc/Hexane).   IR (film, CDCl3) 3325, 2960, 1741, 1720, 1529, 1234, 
1154, 1139, 1030, 929  1H NMR (300 MHz, CDCl3): δ = 7.39-7.26 (m, 5H) ArH, 5.40 (m, 
2H) H-1, H-3; 5.30 (d, 1H, J = 9.2 Hz) NH, 4.74 (d, 1H, J = 20.7 Hz) CH2Ph,  4.70 (d, 1H, 
 J = 20.7 Hz, CH2Ph, 4.61 (d, 1H, J = 11.7 Hz) CH2CCl3, 4.43 (d, 1H J = 11.7 Hz) 
CH2CCl3,  4.41 (m, 2H) H-4, H-5, 3.94 (m, 1H) H-6, 3.74 (m, 2H) H-2, H-6; 2.79-2.64 
(m, 4H) CH2CH2COCH3, 2.16 (s, 3H) CH2CH2COCH3.  13C NMR (75 MHz, CDCl3):  δ = 
206.1, 171.6, 153.4, 137.3, 128.5, 128.1, 127.8, 100.3, 95.2, 74.8, 73.3, 71.5, 70.1, 68.2, 
64.9, 53.9, 37.9, 29.8, 28.1.  HRMS (FAB+) exact mass calcd. for [M+H]+ 
((C21H25O8NCl3) requires m/z 524.0646, found m/z 524.0628. [α]D = -60.1,  (c = 1.00, 
CHCl3). 
 
(10)  To a solution of compound 9 (51 mg, 0.1 mmol) at 0 °C in freshly distilled acetic acid 
(0.15 mL) was added trimethylsilyl triflate (0.04 mL of a 0.05 M solution in acetic acid).  
The reaction was stirred at 0 °C for 5 hours and then quenched by dilution with ethyl 
acetate (2 mL).  The solution was poured over saturated aqueous sodium bicarbonate (1 
mL), and the layers were separated.  The organic layer was washed with saturated aqueous 
sodium bicarbonate (3x1 mL) and brine (1 mL), dried over sodium sulfate and filtered.  
The solvent was removed via rotary evaporation, and the residue was purified by flash 
chromatography (30-50% EtOAc/Hexane) to afford compound 10 (52 mg) in 83% yield as 
a white solid.  (Rf = 0.4 in 50% EtOAc/Hexane).  IR (film, CDCl3) 3334, 3032, 1955, 1742, 
1537, 1371, 1229, 1155, 1047, 933 1H NMR (300 MHz, CDCl3): δ = 7.37-7.30 (m, 5H) 
ArH, 6.25 (d, 1H, J = 3.6 Hz) H-1, 5.22 (dd, 1H, J = 3.0, 11.4 Hz) H-3, 5.01 (d, 1H, J = 9.9 
Hz) NH, 4.87 (d, 1H, J = 11.4 Hz) CH2CCl3,  4.81 (d, 1H, J = 12.0 Hz) CH2Ph, 4.68 (d, 
1H, J = 12.0 Hz) CH2Ph, 4.64 (m, 1H) H-2, 4.61 (d, 1H J = 11.4 Hz) CH2CCl3, 4.19 (m, 
1H) H-6, 4.05 (m, 2H) H-5, H-6; 3.96 (1H, m) H-4,  2.84-2.48 (m, 4H) CH2CH2COCH3, 
2.18 (s, 3H) COCH3, 2.15 (s, 3H) COCH3, 1.98 (s, 3H) COCH3.  13C NMR (75 MHz, 
 CDCl3):  δ = 206.5, 173.3, 170.6, 169.2, 154.3, 137.6, 128.8, 128.5, 128.3, 91.6, 77.5, 75.3, 
74.9, 73.6, 71.3, 70.5, 62.3, 49.6, 38.0, 30.0, 28.2, 21.1, 21.0. HRMS (FAB+) exact mass 
calcd. for [M+Na]+ (C25H30O11NCl3Na) requires m/z 648.0787, found m/z 648.0783. [α]D = 
+59.7,  (c = 2.00, CHCl3). 
 
(11)  To a solution of 10 (30 mg, 0.048 mmol) in ethanol (0.5 mL) was added sodium 
borohydride (2 mg, 0.06 mmol).  The reaction was stirred for 30 minutes and then 
partitioned between ethyl acetate (3 mL) and water (1 mL).  The organic layer was washed 
with brine (1 mL), dried over sodium sulfate, and filtered.  The solvent was removed via 
rotary evaporation, and the residue was purified via flash chromatography (20-50% 
EtOAc/Hexane) to afford compound 11 (23 mg, 0.043) in 89% yield as a white solid.  (Rf = 
0.15 in 50% EtOAc/Hexanes).  IR (film, CDCl3) 3583, 3437, 3339, 3065, 2954, 2922, 
1742, 1535, 1373, 1229, 1111, 1092, 1045, 1011, 932  1H NMR (300 MHz, CDCl3): δ = 
7.38-7.30 (m, 5H) ArH, 6.23 (d, 1H, J = 3.6 Hz) H-1, 5.02 (d, 1H, J = 8.7 Hz) NH, 4.76 (d, 
1H, J = 12.0 Hz) CH2Ph, 4.75 (s, 2H) CH2CCl3,  4.70 (d, 1H, J = 12.0 Hz) CH2Ph, 4.23 (m, 
2H) H-2, H-3;  4.13 (m, 1H) H-6, 4.04 (m, 1H) H-6, 3.90 (m, 1H) H-4,  3.83 (1H, m) H-5,  
2.27 (d, 1H, J = 9.6 Hz) OH,  2.14 (s, 3H) COCH3, 2.04 (s, 3H) COCH3.  13C NMR (75 
MHz, CDCl3):  δ = 170.7, 169.3, 155.3, 137.6, 129.0, 128.6, 128.3, 91.6, 76.2, 76.0, 75.1, 
70.6, 70.1, 62.7, 52.0, 21.3, 21.1. HRMS (FAB+) exact mass calcd. for [M+H]+ 
(C20H25O9NCl3) requires m/z 528.0595, found m/z 528.0604. [α]D = +23.5,  (c = 1.00, 
CHCl3). 
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(12) Donor 4 (300 mg, 0.41 mmol) and acceptor 8 (175 mg, 0.41 mmol) were azeotroped 
three times with toluene placed under vacuum for 8 hours.  They were then added as a 
solution in dichloromethane (2 mL) to a flame-dried flask containing flame-activated 4Å 
molecular sieves and dichloromethane (6 mL).  The reaction mixture was allowed to stir for 
30 minutes before N-iodosuccinimide (111 mg, 0.493 mmol) was added under argon, and 
the reaction was allowed to stir for an additional 15 minutes. The reaction was then cooled 
to -40 °C.  A solution of trimethylsilyl triflate in dichloromethane (1.64 mL, 0.05 M) was 
cooled to -78 °C and added to the reaction.  The reaction was warmed to -10 °C and held at 
that temperature for 72 hours.  The reaction was quenched by adding saturated aqueous 
sodium thiosulfate with pyridine (5 mL Na2S2O3 (aq.) with 0.25 mL pyridine) and agitated 
until the red color changed to yellow. The reaction was partitioned between ethyl acetate 
(100 mL) and saturated aqueous sodium thiosulfate (25 mL).  The aqueous layers were 
extracted with ethyl acetate (2x25 mL), and the organics were combined and washed with 
brine (25 mL).  The organic layer was dried over sodium sulfate and filtered, and the 
solvent was removed via rotary evacuation.  The residue was purified via flash 
chromatography (10-35% EtOAc/Hexane) to provide compound 12 (266 mg) in 62% yield 
as a white solid.   1H NMR (300 MHz, CDCl3): δ = 7.98-7.24 (m, 10H) Ar-H,  5.46 (dd, 
 1H) H-3 GlcA, 5.16 (apparent s, 1H) H-1 GalN, 5.03 (d, 1H, J = 1.2 Hz) H-1 GlcA, 4.95 
(d, 1H, J = 9.0 Hz) NH, 4.69 (dd, 1H) H-2 GlcA, 4.58-4.42 (m, 5H) CH2CCl3, CH2OBn, 
H-4 GalN, 4.21 (m, 1H) H-5 GalN, 4.06 (dd, 1H) H-4 GlcA, 3.93 (apparent d, 1H) H-2 
GalN, 3.85 (apparent s, 2H) H-6 GlcA, 3.75-3.69 (m, 2H) H-6 GalN, H-5 GlcA, 3.56-3.48 
(m, 2H) H-3 GalN, H-6 GalN, 2.00 (s, 3H) C(O)CH3, 1.10 (m, 21H) TIPS, 0.98 (m, 21H, 
TIPS).  13C NMR (75 MHz, CDCl3):  δ = 169.7, 165.7, 153.2, 137.5, 132.9, 130.3, 129.4, 
128.6, 128.2, 128.0, 127.5, 100.2, 99.4, 95.4, 77.2, 74.9, 74.6, 73.7, 72.9, 72.2, 71.2, 70.0, 
65.7, 65.0, 61.7, 54.7, 20.7, 18.1, 18.0, 18.0, 17.9, 12.9, 12.2.  LRMS (Ion Spray) exact 
mass calcd. for [M+Na]+ (C49H74Cl3NNaO13Si2) requires m/z 1068.3, found m/z 1068.0. 
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(13)  Donor 6 (19 mg, 0.03 mmol) and acceptor 8 (16 mg, 0.04 mmol) were 
azeotroped three times with toluene placed under vacuum for 8 hours.  They were then 
added as a solution in dichloromethane (0.1 mL) to a flame dried flask containing flame-
activated 4Å molecular sieves and dichloromethane (0.2 mL).  The reaction mixture was 
allowed to stir for 30 minutes before N-iodosuccinimide (14 mg, 0.06 mmol) was added 
under argon, and the reaction was allowed to stir for an additional 15 minutes. The reaction 
was then cooled to -40 °C.  A solution of trimethylsilyl triflate in dichloromethane (0.44 
mL, 0.05 M) was cooled to -78 °C and added to the reaction.  The reaction was warmed to -
10 °C and held at that temperature for 17 hours.  The reaction was quenched by adding 
saturated aqueous sodium thiosulfate with pyridine (0.5 mL of a solution containing 5 mL 
 Na2S2O3 (aq.) and 0.25 mL pyridine) and agitated until the red color changed to yellow. 
The reaction was partitioned between ethyl acetate (5 mL) and saturated aqueous sodium 
thiosulfate (2 mL).  The aqueous layers were extracted with ethyl acetate (2x5 mL), and the 
organics were combined and washed with brine (10 mL).  The organic layer was dried over 
sodium sulfate and filtered, and the solvent was removed via rotary evacuation.  The 
residue was purified via flash chromatography (10-35% EtOAc/Hexane) to provide 
compound 13 (15 mg) in 53% yield as a white solid.  1H NMR (300 MHz, CDCl3): δ = 
7.99–7.17 (m, 10H) Ar-H, 6.09 (d, 1H, J = 3.9 Hz) H-1 GlcA, 5.49 (dd, 1H, J = 2.4, 2.1 
Hz) H-3 GlcA, 5.34 (apparent s, 1H) H-1 GalN, 5.15 (d, 1H, J = 9.3 Hz) NH, 4.71 (d, 1H, J 
= 11.7 Hz), 4.59-4.35 (m, 7H), 4.23-4.13 (m, 3H), 3.72-3.64 (m, 2H), 3.59 (s, 3H) 
CO2CH3, 1.88 (s, 3H) C(O)CH3, 1.07 (m, 21H) CH(CH3)2.  13C NMR (125 MHz, CDCl3):  
δ = 171.5, 170.3, 164.9, 153.6, 137.7, 133.9, 130.2, 128.8, 128.7, 128.2, 127.8, 124.3, 
100.6, 95.4, 74.9, 74.8, 74.7, 73.5, 71.1, 70.6, 70.1, 69.1, 68.1, 65.2, 60.6, 54.6, 52.4, 24.5, 
18.1, 18.1, 12.5.  LRMS (Ion Spray) exact mass calcd. for [M+Na]+ (C41H54Cl3NNaO14Si) 
requires m/z 940.2, found m/z 940.0. 
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(14)  Donor 6 (100 mg, 0.17 mmol) and acceptor 11 (92 mg, 0.18 mmol) were 
azeotroped three times with toluene placed under vacuum for 8 hours.  They were then 
added as a solution in dichloromethane (1 mL) to a flame-dried flask containing flame- 
activated 4Å molecular sieves and dichloromethane (2.4 mL).  The reaction mixture was 
 allowed to stir for 30 minutes before N-iodosuccinimide (52 mg, 0.23 mmol) was added 
under argon, and the reaction was allowed to stir for an additional 15 minutes. The reaction 
was then cooled to -40 °C.  A solution of trimethylsilyl triflate in dichloromethane (0.6 mL, 
0.05 M) was cooled to -78 °C and added to the reaction.  The reaction was warmed to 0 °C 
and held at that temperature for 10 hours.  The reaction was quenched by adding saturated 
aqueous sodium thiosulfate with pyridine (2 mL of a solution containing 5 mL Na2S2O3 
(aq.) and 0.25 mL pyridine) and agitated until the red color changed to yellow. The reaction 
was partitioned between ethyl acetate (15 mL) and saturated aqueous sodium thiosulfate 
(10 mL).  The aqueous layers were extracted with ethyl acetate (2x5 mL), and the organics 
were combined and washed with brine (10 mL).  The organic layer was dried over sodium 
sulfate and filtered, and the solvent was removed via rotary evacuation.  The residue was 
purified via flash chromatography (10-40% EtOAc/Hexane) to provide compound 14 (109 
mg) in 63% yield as a white solid.  1H NMR (500 MHz, CDCl3): δ = 7.91 (d, 2H, J = 7.5 
Hz) ArH, 7.51 (t, 1H, J = 7.5 Hz) ArH, 7.37-7.22 (m, 7H) Ar-H, 6.19 (d, 1H, J = 3.5 Hz) 
Gal H-1, 5.30 (dd, 1H, J = 8.5, 9.0 Hz) Glu H-3, 5.05 (dd, 1H, J = 8.0, 9.0 Hz) Glu H-4, 
4.97-4.89 (m, 4H) CH2CCl3, Glu H-5, NH; 4.70 (d, 1H, J = 12.0 Hz) CH2Ph, 4.60 (d, 1H, J 
= 12 Hz) CH2Ph, 4.50 (m, 1H), 4.44 (m, 1H), 4.40 (dd, 1H, J = 8.5, 8.5 Hz), 4.07 (d, 1H, J 
= 8.5 Hz) Glu H-1, 4.04 (m, 1H), 3.96 (m, 8H), 3.73 (s, 3H) CO2CH3, 3.69 (m, 1H),  2.10 
(s, 3H) C(O)CH3, 1.91 (s, 3H) C(O)CH3, 1.86 (s, 3H) C(O)CH3, 0.89-0.84 (m, 21H) 
CH(CH3)2.  13C NMR (125 MHz, CDCl3):  δ =170.8, 170.1, 169.1, 168.5, 165.8, 154.7, 
138.0, 133.7,130.1, 129.6, 128.8, 128.5, 128.1, 128.0, 94.3, 91.9, 91.6, 76.7, 76.6, 75.1, 
74.9, 74.7, 72.0, 71.1, 70.7, 63.1, 62.1, 52.5, 49.8, 21.4, 21.2, 20.9, 18.1, 12.4.  LRMS (Ion 
 Spray) exact mass calcd. for [M+Na]+ (C45H60Cl3NNaO17Si) requires m/z 1042.3, found 
m/z 1042.0. 
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(15)  To a solution of compound 14 (33 mg, 0.03 mmol) in THF (0.3 mL) was added 
benzylamine (0.01 mL, 0.1 mmol).  The solution was stirred for 7 hours, and the reaction 
was quenched by the addition of ethyl acetate (5 mL) and poured into an extraction funnel.  
The organic layer was washed with water (2x1 mL) and brine (1 mL) and dried over 
sodium sulfate.  The organic layer was filtered, and the solvent was removed via rotary 
evaporation.  The residue was purified via flash chromatography to afford compound 15 
(22 mg) in 74% yield as a white solid.  1H NMR (300 MHz, CDCl3): δ = 7.97 (d, 2H, J = 
6.9 Hz) ArH, 7.60 (t, 1H, J = 7.2 Hz) ArH, 7.49-7.33 (m, 7H) Ar-H, 6.36 (bs, 1H), 5.53 (bs, 
1H), 5.45 (m, 1H), 5.01-4.61 (m, 6H), 4.37 (bs, 1H),  4.28 (m, 1H), 4.20 (bs, 1H), 4.15-
3.81 (m, 5H), 3.48 (s, 3H) CO2CH3, 2.62 (bs, 1H) OH, 1.92 (s, 3H) C(O)CH3, 1.85 (s, 3H) 
C(O)CH3, 0.89-0.84 (m, 21H) CH(CH3)2.  13C NMR (75 MHz, CDCl3):  δ = 170.9, 170.1, 
164.6, 154.9, 138.1, 134.2, 130.2, 128.9, 128.9, 128.6, 128.1, 125.8, 94.2, 93.3, 92.4, 76.5, 
75.4, 74.9, 74.8, 74.7, 70.1, 69.1, 68.8, 68.6, 66.9, 63.9, 52.5, 21.4, 21.0, 18.1, 12.3.  LRMS 
(Ion Spray) exact mass calcd. for [M+Cl’]- (C43H58Cl4NO16Si) requires m/z 1012.2, found 
m/z 1012.1. 
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(16)   Compound 15 (194 mg, 0.2 mmol) was azeotroped three times with toluene and 
placed under vacuum for 8 hours before being added to a flame-dried flask with flame-
activated 4Å molecular sieves as a solution in dichloromethane (3.5 mL).  The reaction 
mixture was allowed to stir for 15 minutes before being cooled to 0 °C for the addition of 
freshly distilled 1,8-diazabicyclo[5.4.0]undec-7-ene (6 μL, 0.04 mmol) and freshly distilled 
trichloroacetonitrile (0.2 mL, 2 mmol).  The reaction was warmed to room temperature to 
stir for 6 hours.  Toluene (0.2 mL) was added to the reaction mixture, which was 
concentrated before loading on a silica column pretreated with a mixture of 
hexane:toluene:ethyl acetate:triethylamine (50:20:20:1).  The column was eluted with a 
mixture of hexane:toluene:ethyl acetate (5:2:2) with triethylamine (0.1 mL), and the 
fractions containing the imidate were concentrated and kept under vacuum for 4 hours 
before being used in the next reaction.   (Rf = 0.5 in hexane:toluene:ethyl acetate (5:2:2) 
with 0.1 mL triethylamine. NOTE:  this compound is easily hydrolyzed so TLC plates must 
be pre-eluted with the hexane:toluene:ethyl acetate:triethylamine solution (50:20:20:1) 
before being spotted.) 
The imidate was added as a solution in dichloromethane (5 mL) to a flame-dried 
flask containing flame-activated 4Å molecular sieves.  Freshly distilled allyl alcohol (0.12 
mL, 1.75 mmol) was added, and the reaction mixture was stirred at room temperature for 
15 minutes before being cooled to -78  °C for the addition of trimethylsilyl triflate as a 
solution in dichloromethane (0.23 mL, 0.05 M).  The reaction was warmed to 0 °C and 
stirred for 6 hours before being quenched by the addition of solution of pyridine in ethyl 
 acetate (0.5 mL pyridine in 20 mL ethyl acetate).  The organic layer was washed with 
saturated aqueous sodium bicarbonate (10 mL) and brine (10 mL), and the organic layer 
was dried over sodium sulfate and filtered.  The solvent was removed via rotary 
evaporation, and the residue was purified via flash chromatography (hexane:toluene:ethyl 
acetate, 5:2:2) to afford compound 16 (122 mg) in 63% yield as a white solid.   (500 MHz, 
CDCl3): δ = 8.01 (dd, 2 H J = 1.5, 8.5 Hz) ArH, 7.96 (m, 1H) ArH, 7.46-7.29 (m, 7H) 
ArH, 5.87 (m, 1H) CH2CHCH2O, 5.38 (dd), 1H, J = 10.0, 10.0 Hz) Glu H-3, 5.28-5.24 (m, 
2H) CH2CHCH2O, NH; 5.18 (m, 1H) CH2CHCH2O, 5.10 (dd, 1H, J = 8.0, 8.0 Hz) Glu H-
4, 4.94 (m, 1H) Glu H-5,  4.89 (d, 1H, J = 29.0) CH2Ph, 4.85 (d, 1H, J = 29.0) CH2Ph, 4.80 
(m, 1H) Gal H-1, 4.71-4.64 (m, 2H) CH2CCl3, 4.53 (m, 1H) Gal H-3, 4.49 (dd, 1H, J = 8.5, 
8.5 Hz) Glu H-2, 4.36-4.31 (m, 2H) CH2CHCH2O, 4.12-4.05 (m, 3H) Glu H-1, 
CH2CHCH2O, Gal H-6; 4.04 (m, 2H) Gal H-4, Gal H-5, 3.81 (s, 3H) CO2CH3, 3.66 (m, 
1H) Gal H-6, 3.53 (m, 1H) Gal H-2, 1.94 (s, 3H) COCH3, 1.93 (s, 3H) COCH3, 0.97-0.85 
(m, 21H) Si(CH(CH3)2)3 13C NMR (125 MHz, CDCl3):  δ = 170.4, 169.4, 160.5, 154.2, 
137.9, 137.2, 133.7, 133.5, 129.6, 129.4, 128.6, 128.5, 128.4, 128.3, 128.2, 125.3, 117.8, 
95.6, 75.1, 74.6, 73.2, 73.0, 72.0, 70.9, 70.9, 70.0, 62.3, 52.5, 50.0, 20.7, 21.5, 20.9, 20.9, 
20.7, 17.9, 12.9.  LRMS (Ion Spray) exact mass calcd. for [M+Na]+ (C46H62Cl3NNaO16Si) 
requires m/z 1040.3, found m/z 1042.1. 
 
 
 
 References 
1. (a) Northrup, A. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 6798.  (b)  
Northrup, A. B.; Mangion, I. K.; Hettche, F.; MacMillan, D. W. C. Angew. Chem. 
Int. Ed.  2004, 43, 2152.  (c) Northrup, A. B.; MacMillan, D. W. C. Science  2004, 
305, 1753. 
2. (a)  Gama, C. I. and Hsieh-Wilson, L. C. Curr. Op. Chem. Biol. 2005, 9, 609. (b) 
Ernst, B.; Hart, G. W.; Sinay, P.; Eds. Carbohydrates in Chemistry and Biology, 
Wiley-VCH: New York, 2000.   
3. (a) Sugahara, K. and Kitagawa, H. Curr. Opin. Struct. Biol. 2000, 10, 518.   (b) 
Kursche-Gullberg, M. and Kjellen, L. Curr. Opin. Struct. Biol.   2003 5, 605.   
4. (a) Rauch, U.; Feng, K.; Zhou, X.-H. Cell. Mol. Life. Sci. 2001, 58, 1842.  (b) 
Kitagawa, H.; Tsutsumi, K.; Tone, Y.; Sugahara, K. J. Biol. Chem.  1997, 272, 50, 
31377.   
5. (a) Herman, T.; Hartwieg, E.; Horvitz, H. R. Proc. Natl Acad. Sci. USA  1999,  96, 
968. (b)  Hwang, H.-Y.;  Horvitz, H. R.  Proc. Natl Acad. Sci. USA  2002,  99,  
14218.  (c) Hwang, H.-Y.; Olson, S. K.; Esko, J. D.; Horvitz, H. R. Nature, 2003, 
423, 439.   
 
6. (a) Kluppel, M.; Wight, T.N.; Chan, C.; Hinek, A.; Wrana, J.L.  Development 2005, 
132, 3989.  (b) Thiele, H.; Sakano, M.; Kitagawa, H.; Sugahara, K.; Rajab, A.; 
Hohne, W.; Ritter, H.; Leschik, G.; Nurnberg, P.;  Mundlos, S.  Proc. Natl. Acad. 
Sci. USA, 2004,  101, 10155.   
  
7. (a)  Yang, J.; Price, M.A.; Neudauer, C.L.; Wilson, C.; Ferrone, S.; Xia, H.; Iida, J.; 
Simpson, M.A.; McCarthy, J.B.  J. Cell Biol. 2004, 165, 881.  (b) Heredia, A.; 
Villena, J.; Romaris, M.; Molist, A.;  Bassols, A. Arch. Biochem. Biophys. 1996, 
333, 198.  (c) Lu, H.; Yu, G.; Sun, L.; Zhang. Z.; Zhao, X.; Chai, W. Oncology 
2007, 72, 347.  (d)  Pothacharoen, P.; Ong-Chai, S.; Supaphun, J.; Kumia, P.; 
Wanaphirak, C.; Sugahara, K.; Hardingham, T.; Kongtawelert, P. J. Biochem. 
(Tokyo) 2006, 140, 517.  (e) Theocharis, A. D.; Tsara, M. E.; Papageorgacopoulou, 
N.; Karavias, D. D.; Theocharis, D. A. Biochim. Biophys. Acta 2000, 1502, 2, 201. 
(f) Theocharis, A. D.; Vynios, D. H.; Papageorgakopoulou, N.; Skandalis, S. S.; 
Theocharis, D. A. Int. J. Biochem. Cell Biol. 2003, 35, 3, 376.   
8. Nadanaka, S.; Clement, A.; Masayama, K.; Faissner, A.; Sugahara, K. J. Biol. 
Chem. 1998, 278, 6, 3296.   
9. Bradbury, E.J.; Moon, L.D.; Popat, R.J.; King, V.R.; Bennett, G.S.; Patel, P.N.; 
Fawcett, J.W.;  McMahon, S.B.  Nature, 2002, 416, 636.   
10. (a) Tully, S. E.; Mabon, R.; Gama, C. I.; Tsai, S. M.; Liu, X.; Hsieh-Wilson, L. C. 
J. Am. Chem. Soc. 2004, 126, 7736.  (b) Gama, C. I.; Tully, S. E.; Sotogaku, N.; 
Clark, P. M.; Rawat, M.; Vaidehi, N.; Goddard, W. A.; Nishi, A.; Hsieh-Wilson, L. 
C. Nature Chem. Biol. 2006, 2, 9, 467.  
11. Marra, A.; Dong, X.; Petitou, M.; Sinay, P. Carbohydr. Res. 1989, 195, 39.   
 12. Schmidt, R. R.  Angew. Chem. Int. Ed. Engl. 1986, 25, 212.   
13. Jacquinet, J. C.  Carbohydr. Res. 1990, 199, 153.   
14. (a) Tamura, J.; Neumann, K. W.; Kurono, S.; Ogawa, T. Carbohydr. Res.  1997, 
305, 43.  (b)  Tamura, J.; Neumann, K. W.; Ogawa, T. Bioorg. Med. Chem. Lett. 
1995, 5, 1351.   
15. Karst, N.; Jacquinet, J. C. Eur. J. Org. Chem. 2002, 815.  
 
16. Tully, S. E. Synthesis and Biological Activity of Chondroitin Sulfate Biopolymers, 
2007, Ph. D. Thesis, California Institute of Technology.  
 
17. (a) Ellervik, U.; Magnusson, G. Carbohydr. Res. 1996, 280, 2, 251.  (b) Xue, J.; 
Khaja, S. D.; Locke, R. D.; Matta, K. L. Synlett 2004, 5, 861.  (c)  Yan, F.; Mehta, 
S.; Eichler, E.; Wakarchuk, W. W.; Gilbert, M.; Schur, M. J.; Whitfield, D. W. J. 
Org. Chem. 2003, 68, 2752.   
 
18. Tully, S. E.; Rawat, M.; Hsieh-Wilson, L. C. J. Am. Chem. Soc. 2006, 128, 24, 
7740.   
 
19. (a) Rucker, C. Chem. Rev., 1995, 95, 1009.  (b) Eisneberg, C.; Knochel, P. J. Org. 
Chem. 1985, 50, 4021.  (c) Knight, D. W; Shaw, D.; Fenton, G. Synlett, 1994, 295.   
 
 20. Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 3rd Ed.  
Wiley: New York, 1999. 
 
21. Egusa, K.; Kusumoto, S.; Fukase, K. Eur. J. Org. Chem. 2003, 17, 3435.  
 
22. (a) Takatani, M.; Matsuo, I.; Yukishige, I. Carbohydr. Res. 2003, 10, 1, 1073. (b) 
Fukase, K.; Matsumoto, T.; Ito, N.; Yoshimura, T.; Kotani, S.; Kusumoto, S.  Bull. 
Chem. Soc. Jpn. 1992, 65, 10, 2643.  (c) Brard, M.; Richter, W.; Benvegnu, T.; 
Plusquellec, D. J. Am. Chem. Soc. 2004, 126, 10003.  (d)  Stepowska, H.; Zamojski, 
A. Pol. J. Chem. 1994, 68, 11, 2229.   
 
23. Arndt, S.; Hsieh-Wilson, L. C. Org. Lett. 2003, 5, 4197.   
 
24. It is important to note that while the acetoxyaldehyde proved safe to distill many 
times, an explosion did occur during one distillation despite the liquid to be distilled 
showing no signs of the ozonide either when tested with KI paper or when analyzed 
by 1H NMR.   
 
25. (a) Kozikowski, A. P.; Lee, J. J. Org. Chem. 1990, 55, 3, 863. (b) Koto, S.; Asami, 
K.; Hirooka, M.; Nagura, K.; Takizawa, M.; Yamamoto, S.; Okamoto, N.; Mitsuko, 
S.; Tajima, H.; Yoshida, T.; Nonaka, N.; Sato, T.; Zen, S.; Yago, K.; Tomonaga, F. 
Bull. Chem. Soc. J.  1999, 72, 4, 765.  
 
 26. Leteux, C.; Veyrieres, A. J. Chem. Soc., Perkin Trans. 1 1994, 2647. 
 
27. Cerny, M.; Julakova, O.; Pacak, J. Coll. Czech. Chem. Comm. 1974, 39, 5. 1391.  
 
28. Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. 
Organometallics 1996, 15, 1518.  
29. Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed. 
Pergamon Press, Oxford, 1988 
30. W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
 
31. This research was carried out in the Hsieh-Wilson laboratory with the assistance of 
Drs. Song-Gil Lee and Sarah Tully, Ms. Maria Chiriac, and Mr. Robinson 
Moncure.  
 
32. Figures in this section were modified from Tully, S. E. Synthesis and Biological 
Activity of Chondroitin Sulfate Biopolymers, 2007, Ph. D. Thesis, California 
Institute of Technology.  
 
 
 C h a p t e r  4  
Development of Selective Deprotection Conditions to Elaborate the Core Chondroitin 
Sulfate Disaccharide 17 
Introduction  
            Chondroitin sulfate (CS) is a linear polysaccharide composed of repeating 
glucuronic acid (GlcA) and galactosamine (GalNAc) residues. This polymeric scaffold can 
be sulfated at any of the free hydroxyls along the chain to produce a range of sulfation 
patterns (which are denoted by letter, such as CS-A, CS-C, CS-D, and CS-E (Figure 4.1)).1   
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Figure 4.1:  Chondroitin sulfate is a linear polysaccharide composed of repeating GlcA and 
GalNAc residues.  It can be sulfated along the backbone to produce a heterogeneous 
polymer composed of a range of sulfation patterns.  Each pattern is denoted by a letter.   
 
 
Many studies have been conducted to investigate the effects of sulfation on the biological 
activity of CS, but until recently, these studies were performed on CS natural isolates that, 
 while enriched in a certain sulfation pattern, still contain other CS motifs.2  Recent work in 
the Hsieh-Wilson laboratory has established that the bioactivity of CS lies in its sulfation 
pattern.3   Using synthetic CS tetrasaccharides with defined sulfation motifs, they were able 
to show that one sulfation pattern, CS-E, stimulated axonal growth in hippocampal, 
dopaminergic, and dorsal root ganglion (DRG) neurons.  Specifically, the synthetic 
tetrasaccharides were coated with polyornithine onto glass coverslips.  Neurons were 
cultured on these coverslips for 48 hours, after which they were fixed and immunostained 
with an antibody to tubulin.  They were examined by confocal fluorescence microscopy to 
quantify neurite length.  CS-E stimulated neurite outgrowth up to 50% when compared to 
the polyornithine control in all three types of neurons.    CS-C and CS-R did not 
significantly stimulate neurite outgrowth.  CS-A did display some stimulatory activity at 
high concentrations (500 go/mL) with hippocampal neurons, but did not display significant 
stimulatory effects with the dopaminergic or DRG neurons (Figure 4.2). 
  
Figure 4.2:  CS-E stimulated neurite outgrowth in dopaminergic, hippocampal, and dorsal 
root ganglion neurons.    
 
 
            Further studies determined that CS-E stimulates neuronal growth by binding both 
midkine and BDNF (brain-derived neurotropic factor).  Microarray technology developed 
in our laboratory showed that CS-E interacts with the growth factors midkine and BDNF.  
Using a high-precision contact-printing robot, CS-A, CS-C, CS-E, and CS-R 
tetrasaccharides were spotted on aldehyde-coated slides.  These tetrasaccharides were 
synthesized from the original allyl-tetrasaccharides through a two-step procedure:  First the 
allyl group on each tetrasaccharide was ozonolyzed to the aldehyde, and this aldehyde was 
reacted with oxime linker 1 to produce the activated tetrasaccharides (Figure 4.3).  The 
 oxime linker allowed these tetrasaccharides to covalently attach to the aldehyde plates.  
After washing the plates and quenching any unreacted aldehyde moieties on the suface, the 
micorarrays were probed with midkine and BDNF.  Both growth factors were found to 
selectively bind to CS-E at 5 μM concentration.   
            To confirm the involvement of these growth factors, antibodies against midkine, 
BDNF, and fibroblast growth factor-1 (FGF-1) were added separately to plates containing 
hippocampal neurons cultured either on a substratum of polyornithine or polyornithine plus 
CS-E tetrasaccharide.   As expected, CS-E stimulated neuronal growth almost 50% above 
control in the plates without added antibodies.  However in plates with antibodies to 
midkine and BDNF, the ability of CS-E to stimulate neuronal growth was blocked.  An 
antibody to FGF-1 had no affect on the ability of CS-E to stimulate neuronal growth, which 
was expected since CS-E is not known to operate through FGF-1.3   
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Figure 4.3:  The allyl group can be used as a chemical handle for attaching tetrasaccharides 
to surfaces or other molecules.  
 
            These studies demonstrated the value of synthetic CS saccharides for probing the 
roles that sulfation plays in neuronal growth and development.  With this in mind, we set 
 out to design a core disaccharide 2 from which any desired sulfation pattern could be 
accessed (Figure 4.4).  The design and synthesis of this disaccharide is detailed in Chapter 
3.  One goal with this disaccharide is to differentiate each position so that it will allow 
access to oversulfated chondroitin sulfates, such as CS-D, that are suggested to have 
important biological activities.   
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Figure 4.4:  It was envisioned that a core disaccharide such as 2 could allow access to all 
possible sulfation patterns.   
 
            Studies with natural isolates suggest that the oversulfated CS saccharides may 
possess interesting biological functions.  For example, there is evidence to suggest CS-D 
may affect neuronal growth through the binding of pleiotrophin.  Even more interesting is 
the fact that CS-D may stimulate the extension of dendrites.  In work by Sugahara and 
coworkers, hippocampal neurons were grown on coverslips coated with either 
polyornithine or polyornithine plus CS isolates enriched in certain sulfation motifs.  It was 
found that CS-D was able to stimulate the growth of hippocampal neurons almost 60% 
above control.  In further work by the same laboratory, they digested and fractionated CS-E 
polysaccharides (via elution over a pleiotrophin-immobilized affinity column) into two 
pools—low-affinity CS polysaccharides (LACS) and high-affinity CS polysaccharides 
(HACS).    It was found that LACS (which was shown to have CS-D through binding of 
monoclonal antibody 473HD) promoted the outgrowth of dendrites while HACS promotes 
the outgrowth of axon-like neurons.  Further studies have also shown that hippocampal 
neurons plated with CS-D isolates and exogenous pleiotrophin stimulated the growth of 
neurons over polyornithine control and over polyornithine and CS-D without exogenous 
pleiotrophin.   In contrast, when similar studies were performed with CS-E isolates, 
pleiotrophin had no effect on neurite outgrowth, suggesting that CS-D and not CS-E 
operates through the binding of pleiotrophin.  These results suggest each sulfation motif 
triggers distinct pathways (Figure 4.5).5  
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Figure 4.5:  CS-D is believed to stimulate the growth of dendrites through the binding of 
pleiotrophin (PTN).            
 
            Studies with enriched CS-K isolates suggest it blocks retinoic acid receptor (RAR) 
signaling required for neuritogenic differentiation.  Specifically, it was determined that as 
the production of CS-K increases, neurite outgrowth in LA-N-5 cells (a neuroblastoma cell 
line) decreases.  In addition, there are distinct morphological changes between LA-N-5 
cells grown with normal or overstimulated CS-K production.6  Other studies have 
suggested that other oversulfated CSs such as CS-L and CS-M may also effect neuronal 
growth and differentiation.7   
            Our laboratory hopes to evaluate the biological activity of these sulfation patterns 
using synthetic saccharides.  Upon accessing core disaccharide 2 it was necessary to 
 confirm that we could differentiate between the positions before proceeding.   Issues 
specifically examined are as follows:  the ability to convert the Troc group to the desired N-
acetyl group; differentiation of the galactosamine C-6, glucosyl C-2, and glucosyl C-3 
esters; and removal of the galactosamine C-4 benzyl group.   
Testing the Disaccharide Protecting Group Strategy 
            As shown in Scheme 4.1, core disaccharide 2 was obtained via a TMSOTf-
mediated coupling of glucosyl donor 3 and galactosamine acceptor 4.  Removal of the 
anomeric acetate, activation to the imidate, and a TMSOTf-mediated coupling to allyl 
alcohol produced disaccharide 5 (as described in Chapter 3).  Initial efforts focused on 
removing the Troc group in two steps, but this route was low yielding.  Happily, a one-step 
procedure to simultaneously remove the Troc group and reprotect the resulting amine using 
zinc and acetic anhydride produced disaccharide 6 in good yield.8 
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Scheme 4.1:  Core disaccharide 2 was elaborated to form N-acetyl disaccharide 6.   
 
             We next examined if the ester protecting groups could be removed sequentially as 
we planned.  We hoped to be able to deprotect the primary acetate in the presence of the 
secondary acetate and to deprotect both acetates in the presence of the benzoyl protecting 
group.  It was found that 12-hour exposure of disaccharide 6 to hydrazine hydrate in 
ethanol removed the primary acetate, producing a deprotected saccharide that corresponds 
to CS-C.  Extended exposure of disaccharide 6 to hydrazine hydrate removed both acetates 
without removing the glucosyl C-3 benzoyl ester.  This deprotection pattern corresponds to 
CS-D.  Interestingly-when removing the acetyl groups-hydrazine, hydrazine hydrate, and 
hydrazine acetate most often produced the propyl disaccharides 7b and 8b instead of allyl 
disaccharides 7a and 8a.  While hydrazine has been used as a hydrogen source to reduce 
olefins,9 this result was surprising since there are numerous reports of the use of hydrazine 
in the presence of an allyl group with no incident of reduction.10 Even more troublesome is 
that these conditions have on occasion produced allyl disaccharides 7a and 8a (Scheme 
4.2). Despite this unusual observation, it was concluded that hydrazine hydrate allowed 
differentiation between the primary and secondary acetate esters.   
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Scheme 4.2:  Removal of the galactosamine C-6, glucosyl C-2, and glucosyl C-3 esters 
 
            Guanidine has been noted as another method for removing acetate esters in the 
presence of benzoyl esters.11  The free base of guanidine was prepared as described by 
Kunesch and coworkers11a and was combined with disaccharide 6 .  Instead of selectively 
removing the acetates, the reaction quickly proceeded to remove all ester groups to produce 
disaccharide 9.  While it was unfortunate that this method did not allow differentiation of 
the acetates, these conditions did provide us with a way to remove the benzoyl ester 
without affecting the silyl and benzyl ethers (Scheme 4.2).  
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 Scheme 4.3:  The galactosamine C-4 benzyl group can be removed with palladium 
hydroxide, though these conditions also lead to reduction of the allylic olefin.   
 
 
            The final group to be evaluated was the C-4 benzyl ether.  While we were confident 
we could remove the benzyl group in the presence of the ester and silyl protecting groups, 
we were hopeful that we could remove it without reducing the allyl group.  There have 
been reports in the literature where benzyl protecting groups have been removed without 
reducing allyl protecting groups on the same molecule.12  Our first attempts involved 
exposing disaccharide 6 to palladium hydroxide in acetic acid and methanol under an 
atmosphere of hydrogen (Scheme 4.5).  These conditions produced both disaccharides 10a 
and 10b.  In addition, this reaction also produced several monosaccharide byproducts 
which are believed to be the result of the acidity of these reaction conditions.  Reduction in 
the amount of acetic acid prevented hydrolysis of the glycosidic bond, but this also favored 
formation of disaccharide 10b (Table 4.1).  Work is ongoing to determine selective reaction 
conditions.  If methods cannot be developed to preserve the allyl group, other functional 
handles are available that are compatible with hydrogenation conditions.13    
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Table 4.1:  Hydrogenolysis of the galactosamine C-4 benzyl group.  The ratio of 10a to 10b 
was determined by LCMS analysis of the crude reaction mixture.   
 
            Another concern was that the remaining protecting groups would not be stable to 
the acidity of the sulfation reaction.  To test the stability of the disaccharide to these 
conditions, disaccharide 8b was exposed to 30 equivalents of SO3-TMA in 
dimethylformamide.   Unfortunately, instead of producing the 2,6-sulfated disaccharide, the 
products of this reaction were monosaccharides.  The pH of this reaction was monitored, 
and it was determined that it rapidly became strongly acidic (pH 3~4).  To counter this, 
triethylamine was added to maintain a pH of 6~8, but this reaction did not proceed to a 
sulfated disaccharide and the starting material began to decompose.  It was thought that the 
large excess of SO3-TMA may be the cause of this decomposition pathway, so 3 
equivalents of SO3-TMA were used.  This resulted in progression to a monosulfated 
disaccharide (determined by MS of the reaction), and the addition of 20 more equivalents 
of SO3-TMA permitted the formation of the disulfated product (11, Scheme 4.4).     
 OPropylO
BnO
O
AcHN
O
OH
BzO
TIPSO
MeO2C
OH
8b
SO3zTMA, DMF, 60 oC
OPropylO
BnO
O
AcHN
O
OSO3-
BzO
TIPSO
MeO2C
OSO3-
11  
Scheme 4.4:  Sulfation of disaccharide 8b 
 
Conclusions 
            The sulfation patterns expressed by CS are responsible for the biological activity it 
displays.  To determine the activities associated with each sulfation pattern, it is necessary 
to create a disaccharide that allows differentiation between the glucosyl 2- and 3-hydroxyl 
groups and the galactosamine 4- and 6-hydroxyl groups.  It was determined that the 
protecting group scheme chosen for the core disaccharide will allow differentiation around 
the disaccharide.  Unfortunately, it is not clear that the allyl group can easily be preserved, 
so other chemical handles may need to be explored.  
 Supporting Information 
 
General Methods 
 
Unless stated otherwise, reactions were performed in oven-dried  glassware that had 
been cooled in a desiccator over Dririte.  Reactions were performed under an argon 
environment unless otherwise stated.  All solvents were purified using the method of 
Grubbs.28 Unless stated otherwise, all commercially obtained reagents were used as 
received. Chemicals that were purified after purchase were purified according to the 
guidelines provided by Perrin and Armarego.29 Organic solutions were concentrated under 
reduced pressure on a Büchi rotary evaporator using an ice-water bath for volatile samples.  
High-performance liquid chromatography (HPLC) was performed on Hewlett-Packard 
1100 Series chromatographs using a Chiralcel OD-H column (25 cm) and OD-H guard (5 
cm) as noted.  Liquid chromatography mass spectrometry analysis was performed on an 
Aglient 1100 series LCMS with an acetonitrile/water mobile phase treated with 0.1% acetic 
acid with a quadrapole detector. Thin-layer chromatography (TLC) was performed using E. 
Merck silica gel 60 F254 precoated plates (0.25 mm). Visualization of the developed 
chromatogram was performed by fluorescence quenching, cerium ammonium molybdate 
stain,  p-anisaldehyde, potassium permanganate stain, or ninhydrin stain, as necessary. 
Flash chromatography was performed on ICN silica gel (particle size 0.032 - 0.063 mm) 
using the method of Still.30  
 1H NMR and proton decoupling spectra were recorded on a Varian Mercury 300 
(300 MHz) or a Varian Inova 500 (500 MHz) and the 1H NMR spectra are reported in parts 
per million (δ) relative to the residual solvent peak. Data for 1H are reported as follows: 
chemical shift (δ, ppm), multiplicity (s = singlet, bs = broad singlet, d = doublet, t = triplet, 
q = quartet, m = multiplet), coupling constant(s) in Hz, and integration. 13C NMR spectra 
were obtained on a Varian Mercury 300 (75 MHz) spectrometer and 500 (125 MHz) 
spectrometer and are reported in parts per million (δ) relative to the residual solvent peak. 
IR spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in 
terms of frequency of absorption (cm-1). A JASCO P-1010 instrument was used to measure 
optical rotation. Mass spectra obtained from the Protein/Peptide MicroAnalytical 
Laboratory were generated on a Perkin Elmer/Sciex API 365 triple quadrapole mass 
spectrometer with nano spray ion source. Samples were dissolved in 50/50 MeOH/CH2Cl2, 
and infused at 0.2 microliter per minute.  High-resolution mass spectrometry was 
performed at the Mass Spectrometry Facility at the California Institute of Technology on 
either a JEOL JMS-600H High Resolution Mass Spectrometer or a UPLC-LCT Premier 
XT TOF Mass Spectrometer using Leu-Enkephalin as lock mass in order to obtain exact 
mass.  The UPLC-LCT Premier XT was purchased in 2006 with a grant from the National 
Science Foundation Chemistry Research Instrumentation and Facilities Program (CHE-
0541745). 
 
 Synthesis of the Disaccharides 
O
BnO
O
NHTroc
OAllyl
OAc
OTIPSO
BzO
OAc
MeO2CO
BnO
O
NHTroc
OH
OAc
OTIPSO
BzO
OAc
MeO2C
1. DBU, TCA, DCM
2. Allyl-OH, TMSOTf,
    DCM, 4Å sieves
1 2  
(2)   Compound 1 (194 mg, 0.2 mmol) was azeotroped three times with toluene and placed 
under vacuum for 8 hours before being added to a flame-dried flask with flame-activated 
4Å molecular sieves as a solution in dichloromethane (3.5 mL).  The reaction mixture was 
allowed to stir for 15 minutes before being cooled to 0 °C for the addition of freshly 
distilled 1,8-diazabicyclo[5.4.0]undec-7-ene (6 μL, 0.04 mmol) and freshly distilled 
trichloroacetonitrile (0.2 mL, 2 mmol).  The reaction was warmed to room temperature to 
stir for 6 hours.  Toluene (0.2 mL) was added to the reaction mixture, which was 
concentrated before loading on a silica column pretreated with a mixture of 
hexane:toluene:ethyl acetate:triethylamine (50:20:20:1).  The column was eluted with a 
mixture of hexane:toluene:ethyl acetate (5:2:2) with triethylamine (0.1 mL), and the 
fractions containing the imidate were concentrated and kept under vacuum for 4 hours 
before being used in the next reaction.   (Rf = 0.5 in hexane:toluene:ethyl acetate (5:2:2) 
with 0.1 mL triethylamine.  NOTE:  this compound is easily hydrolyzed so TLC plates 
must be pre-eluted with the hexane:toluene:ethyl acetate:triethylamine solution 
(50:20:20:1) before being spotted.) 
The imidate was added as a solution in dichloromethane (5 mL) to a flame-dried 
flask containing flame-activated 4Å molecular sieves.  Freshly distilled allyl alcohol (0.12 
mL, 1.75 mmol) was added, and the reaction mixture was stirred at room temperature for 
15 minutes before being cooled to -78  °C for the addition of trimethylsilyl triflate as a 
 solution in dichloromethane (0.23 mL, 0.05 M).  The reaction was warmed to 0 °C and 
stirred for 6 hours before being quenched by the addition of solution of pyridine in ethyl 
acetate (0.5 mL pyridine in 20 mL ethyl acetate).  The organic layer was washed with 
saturated aqueous sodium bicarbonate (10 mL) and brine (10 mL), and the organic layer 
was dried over sodium sulfate and filtered.  The solvent was removed via rotary 
evaporation, and the residue was purified via flash chromatography (hexane:toluene:ethyl 
acetate, 5:2:2) to afford compound 1 (122 mg) in 63% yield as a white solid.   (500 MHz, 
CDCl3): δ = 8.01 (dd, 2 H J = 1.5, 8.5 Hz) ArH, 7.96 (m, 1H) ArH, 7.46-7.29 (m, 7H) 
ArH, 5.87 (m, 1H) CH2CHCH2O, 5.38 (dd), 1H, J = 10.0, 10.0 Hz) Glu H-3, 5.28-5.24 (m, 
2H) CH2CHCH2O, NH; 5.18 (m, 1H) CH2CHCH2O, 5.10 (dd, 1H, J = 8.0, 8.0 Hz) Glu H-
4, 4.94 (m, 1H) Glu H-5,  4.89 (d, 1H, J = 29.0) CH2Ph, 4.85 (d, 1H, J = 29.0) CH2Ph, 4.80 
(m, 1H) Gal H-1, 4.71-4.64 (m, 2H) CH2CCl3, 4.53 (m, 1H) Gal H-3, 4.49 (dd, 1H, J = 8.5, 
8.5 Hz) Glu H-2, 4.36-4.31 (m, 2H) CH2CHCH2O, 4.12-4.05 (m, 3H) Glu H-1, 
CH2CHCH2O, Gal H-6; 4.04 (m, 2H) Gal H-4, Gal H-5, 3.81 (s, 3H) CO2CH3, 3.66 (m, 
1H) Gal H-6, 3.53 (m, 1H) Gal H-2, 1.94 (s, 3H) COCH3, 1.93 (s, 3H) COCH3, 0.97-0.85 
(m, 21H) Si(CH(CH3)2)3 13C NMR (125 MHz, CDCl3):  δ = 170.4, 169.4, 160.5, 154.2, 
137.9, 137.2, 133.7, 133.5, 129.6, 129.4, 128.6, 128.5, 128.4, 128.3, 128.2, 125.3, 117.8, 
95.6, 75.1, 74.6, 73.2, 73.0, 72.0, 70.9, 70.9, 70.0, 62.3, 52.5, 50.0, 20.7, 21.5, 20.9, 20.9, 
20.7, 17.9, 12.9.  LRMS (Ion Spray) exact mass calcd. for [M+Na]+ (C46H62Cl3NNaO16Si) 
requires m/z 1042.3, found m/z 1042.1. 
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(3)  Compound 2 (52 mg, 0.05 mmol) was stirred with activated zinc dust (13.4 mg, 
20.4 mmol) in acetic anhydride (1 mL)  for 12 hours, and the reaction was diluted with 
ethyl acetate (5 mL), filtered over celite, and the mother liquor was washed with saturated 
aqueous sodium bicarbonate (3x3 mL) and brine (3 mL).  The organic layer was 
concentrated via rotary evaporation, and the residue was purified via flash chromatography 
(40-70% EtOAc/Hexane) to afford compound 3 (35 mg) as a white solid in 78% yield.   1H 
NMR (500 MHz, CDCl3): δ = 7.99 (d, 2H, J = 7.0 Hz) Ar-H, 7.57 (t, 1H, J = 7.0 Hz) Ar-H, 
7.44-7.28 (m, 7H) Ar-H, 5.87 (m, 1H) CH2CHCH2O, 5.63 (d, 1H, J = 7.0 Hz) NH, 5.38 
(dd, 1H, J = 8.5, 8.5 Hz) Glu H-3, 5.24 (m, 1H) CH2CHCH2O,  5.17 (m, 1H) 
CH2CHCH2O, 5.09 (dd, 1H, J = 8.0, 8.5 Hz) Glu H-4, 4.98 (d, 1H, J = 8.5 Hz) Gal H-1, 
4.90 (d, 1H, J = 12.5 Hz) CH2Ph, 4.88 (d, 1H, J = 8.5 Hz) Glu H-5, 4.74 (m, 1H) Gal H-3, 
4.66 (d, 1H, J = 11.5 Hz) CH2Ph, 4.47 (dd, 1H, J = 8.5, 8.5 Hz) Glu H-2, 4.14 (m, 1H) Gal 
H-6, 4.10 (d, 1H, J = 11.5 Hz) Glu H-1, 4.05 (m, 2H) CH2CHCH2O, 3.91 (m, 1H) Gal H-
5, 3.89 (m, 1H) Gal H-4, 3.77 (s, 3H) CO2CH3, 3.66 (m, 1H) Gal H-6, 3.39 (m, 1H) Gal H-
2, 2.00 (s, 3H) COCH3, 1.93 (s, 6H) COCH3, 0.95-0.89 (m, 21H) Si(CH(CH3)2). 13C NMR 
(125 MHz, CDCl3):  δ = 171.3, 168.6, 165.8, 138.4, 134.1, 133.6, 129.9, 129.6, 129.5, 
128.7, 128.5, 127.9, 118.1, 101.8, 98.2, 78.2, 76.8, 75.7, 72.7, 72.0, 71.1, 70.3, 63.3, 55.7, 
52.7, 28.1, 27.1, 24.1, 20.9, 18.7, 18.2, 17.8, 13.9, 13.2.  HRMS (FAB+) exact mass calcd. 
for [M+H]+ (C45H64NO15Si) requires m/z 886.4045, found m/z 886.4028. 
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(4) To a solution of compound 3 (10 mg, 0.01 mmol) in ethanol (0.2 mL) was 
added hydrazine hydrate (50-60% solution, 0.12 mL), and the reaction was allowed to stir 
for 13 hours.  The reaction was diluted with ethyl acetate (2 mL) and then washed with 
water (1 mL) and brine (1 mL).  The organic layer was dried over sodium sulfate, filtered, 
and concentrated in vacuo.  The residue was purified via flash chromatography (30-80% 
EtOAc/Hexane) to afford compound 4 (6.9 mg, 82% yield) as a white solid.  1H NMR (500 
MHz, CDCl3): δ = 7.99 (d, 2H, J = 7.5 Hz) Ar-H, 7.57 (t, 1H, J = 7.5 Hz) Ar-H, 7.44-7.29 
(m, 7H) Ar-H, 5.86 (m, 1H) CH2CHCH2O, 5.64 (d, 1H, J = 7.0 Hz) NH, 5.39 (dd, 1H, J = 
8.5, 8.5 Hz) Glu H-3, 5.26-5.23 (m, 1H) CH2CHCH2O,  5.18-5.16 (m, 1H) CH2CHCH2O, 
5.10 (dd, 1H, J = 8.5, 8.5 Hz) Glu H-4, 4.98 (d, 1H, J = 8.0 Hz) Gal H-1, 4.90-4.88 (m, 2H) 
CH2Ph, Glu H-5; 4.74-4.72 (m, 1H) Gal H-3, 4.69 (d, 1H, J = 12.0 Hz) CH2Ph, 4.48 (dd, 
1H, J = 8.5, 8.5 Hz) Glu H-2, 4.32-4.28 (m, 1H) Gal H-6, 4.11 (d, 1H, J = 8.5 Hz) Glu H-
1, 4.10-4.05 (m, 1H) CH2CHCH2O, 3.90 (m, 1H) CH2CHCH2O, 3.80 (m, 1H) Gal H-4, 
3.77 (s, 3H) CO2CH3, 3.67-3.62 (m, 1H) Gal H-2, 3.49 (m, 1H) Gal H-5, 3.43-3.36 (m, 
1H) Gal H-6, 2.97 (bs, 1H) OH, 2.01 (s, 3H) COCH3, 1.94 (s, 3H) COCH3, 0.95-0.89 (m, 
21H) Si(CH(CH3)2).  13C NMR (125 MHz, CDCl3): δ = 171.2, 169.5, 168.6, 165.8, 138.4, 
134.2, 133.6, 130.0, 129.9, 129.7, 128.7, 128.6, 128.3, 118.0, 101.9, 98.6, 78.5, 77.4, 76.8, 
75.8, 74.5, 74.3, 72.7, 71.1, 70.4, 62.1, 55.8, 52.7, 24.0. 21.0, 18.1, 13.2.  LRMS (Ion 
Spray) exact mass calcd. for [M+Cl]- (C43H61ClNO14Si)- requires m/z 878.4, found m/z 
878.5. 
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(5) To a solution of compound 3 (23 mg, 0.03) in ethanol (0.6 mL) was added 
hydrazine hydrate (50-60% solution, 0.5 mL), and the reaction was allowed to stir for 11 
hours.  The reaction was diluted with ethyl acetate (4 mL) and then washed with water (1 
mL) and brine (1 mL).  The organic layer was dried over sodium sulfate, filtered, and 
concentrated in vacuo.  The residue was purified via flash chromatography (30-80% 
EtOAc/Hexane) to afford compound 5 (19.3 mg, 76% yield) as a white solid.  1H NMR 
(500 MHz, CDCl3): δ = 8.06 (d, 2H, J = 7.0 Hz) Ar-H, 7.59 (t, 1H, J = 7.5 Hz) Ar-H, 7.45-
7.29 (m, 7H) Ar-H, 5.72 (d, 1H, J = 6.5 Hz) NH, 5.28 (dd, 1H, J = 8.5, 8.5 Hz) Glu H-3, 
4.90-4.85 (m, 3H) Gal H-1, Glu H-4, CH2Ph,  4.68 (d, 1H, J = 12.0 Hz) CH2Ph, 4.63 (d, 
1H, J = 7.5 Hz) Glu H-5, 4.52 (m, 1H) Gal H-3, 4.41 (dd, 1H, J = 8.0, 8.5 Hz) Glu H-2, 
4.15-4.11 (m, 1H) Gal H-6, 4.05 (d, 1H, J = 9.0 Hz) Glu H-1, 3.91 (m, 1H) Gal H-6, 3.88 
(m, 1H) Gal H-4, 3.80 (s, 3H) CO2CH3, 3.78 (m, 2H), propyl CH2, 3.66-3.60 (m, 3H) 
propyl CH2, Gal H-5, 3.43-3.41 (m, 1H) Gal H-2, 2.94 (bs, 1H) OH, 1.98 (s, 3H) COCH3, 
1.92 (s, 3H) COCH3, 0.95-0.89 (m, 24H) Si(CH(CH3)2), propyl CH3.  13C NMR (125 MHz, 
CDCl3): δ = 172.1, 170.7, 168.8, 167.0, 138.5, 133.6, 130.0, 129.9, 129.3, 128.6, 128.5, 
127.9, 105.2, 99.7, 80.2, 78.1, 76.8, 74.3, 73.5, 72.1, 71.5, 71.0, 66.1, 63.3, 55.1, 52.6, 24.0, 
22.9, 21.0, 18.2, 18.1, 18.1,13.2, 10.6.  LRMS (Ion Spray) exact mass calcd. for [M+Cl]- 
(C43H63ClNO14Si)- requires m/z 880.4, found m/z 881.5. 
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(6) To a solution of compound 3 (13 mg, 0.015 mmol) in ethanol (0.3 mL) was added 
hydrazine hydrate (50-60% solution, 0.2 mL), and the reaction was allowed to stir for 42 
hours.  The reaction was diluted with ethyl acetate (3 mL) and then washed with water (1 
mL) and brine (1 mL).  The organic layer was dried over sodium sulfate, filtered, and 
concentrated in vacuo.  The residue was purified via flash chromatography (40-80% 
EtOAc/Hexane) to afford compound 6 (8.1 mg, 67% yield) as a white solid.  1H NMR (300 
MHz, CDCl3): δ = 7.98 (d, 2H, J = 7.5 Hz) Ar-H, 7.56-7.30 (m, 8H) Ar-H, 5.87 (m, 1H) 
CH2CHCH2O, 5.62 (bs, 1H) NH, 5.40-5.25 (m, 2H) CH2CHCH2O, Glu H-3, 5.20-5.15 (m, 
1H) CH2CHCH2O, 5.02-4.69 (m, 6H), 4.51-4.45 (m, 2H), 4.07-3.90 (m, 4H), 3.87-3.72 (m, 
2H), 3.78 (s, 3H) CO2CH3, 3.44 (m, 1H) Gal H-2, 2.93 (bs, 1H) OH, 2.89 (bs, 1H) OH, 
2.01 (s, 3H) COCH3, 0.95-0.89 (m, 21H) Si(CH(CH3)2).  LRMS (Ion Spray) exact mass 
calcd. for [M-H]- (C41H58NO13Si)- requires m/z 800.4, found m/z 800.6. 
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 (28)   Compound 27 (23 mg, 0.03 mmol) was dissolved in ethanol (1 mL) and to 
this was added hydrazine hydrate (16 μL).  The reaction was stirred for 38 hours before 
being quenched by the addition of ethyl acetate (5 mL).  The organic layer was washed 
with water (2x1 mL) and brine (1 mL) and dried over sodium sulfate before being filtered 
and concentrated via rotary evaporation.  The residue was purified via flash 
chromatography (50-70% EtOAc/Hexane) to afford compound 28 (21 mg) in a 93% yield 
as a white solid.    1H NMR (500 MHz, CDCl3): δ = 8.05 (m, 2H) ArH, 7.59-7.30 (m, 8H) 
Ar-H, 5.70 (d, 1H, J = 7.0 Hz) NH, 5.29 (dd, 1H, J = 9.0, 9.0 Hz) Glu H-3, 4.88 (d, 1H, J = 
12.0 Hz) CH2Ph, 4.85 (d, 1H, J = 8.5) Gal H-1, 4.72 (m, 1H) Glu H-4,  4.71 (d, 1H, J = 
12.0 Hz) CH2Ph, 4.63 (d, 1H, J = 7.5) Glu H-5, 4.47 (dd, 1H, J = 3.0, 11.0 Hz) Gal H-3, 
4.42 (dd, 1H, 9.0, 9.0 Hz) Glu H-2, 4.05 (d, 1H, J = 9.0 Hz) Glu H-1, 3.87 (m, 1H) Gal H-
4, 3.80 (s, 3H) CO2CH3, 3.77 (m, 2H) propyl CH2, 3.66 (m, 4H) propyl CH2, Gal-H-5, Gal 
H-6) , 3.47 (m, 1H) Gal H-6, 3.43 (m, 1H) Gal H-2. 2.96 (bs, 1H) OH, 2.91 (bs, 1H) OH, 
1.98 (s, 3H) COCH3, 0.97-0.88 (m, 24H) Si(CH(CH3)2, propyl CH3  13C NMR (125 MHz, 
CDCl3):  δ = 172.1, 170.3, 167.0, 153.6, 138.3, 133.6, 129.9, 129.6, 128.7, 128.6, 105.3, 
99.8, 80.5, 76.8, 74.5, 73.6, 71.0, 61.0, 52.7, 24.0, 23.0, 18.2. 18.1, 18.0, 13.2, 10.6.  LRMS 
(Ion Spray) exact mass calcd. for [M-H]-(C41H60NO13Si)- requires m/z 802.4, found m/z 
802.2. 
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 (8) Guanidine (0.7 M solution in ethanol, 10 μL ) was added to a solution of compound 3 
(6 mg, 0.01 mmol) at 0 oC in ethanol (80 μL) and dichloromethane (10 μL).  This reaction 
was stirred for 2 hours and then diluted with ethyl acetate (2 mL).  The organic layer was 
washed with water (0.5 mL) and brine (0.5 mL), and the organic layer was dried over 
sodium sulfate, filtered, and concentrated in vacuo.   The residue was purified via column 
chromatography (60-100% EtOAc/Hexane) to afford compound 8  (3.5 mg, 73 % yield) as 
a white solid.   1H NMR (500 MHz, CDCl3): δ = 7.41-7.30 (m, 5H) Ar-H, 5.88 (m, 1H) 
CH2CHCH2O, 5.64 (d, 1H, J = 7.5 Hz) NH, 5.30 (m, 1H) CH2CHCH2O,  5.18 (m, 1H) 
CH2CHCH2O, 4.86 (d, 1H, J = 12.0 Hz) CH2Ph, 4.77-4.67 (m, 2H), 4.42 (d, 1H, J = 7.5 
Hz), 4.33-4.26 (m, 2H), 4.10-4.06 (m, 2H), 3.88-3.77 (m, 3H), 3.80 (s, 3H) CO2CH3, 3.62-
3.54 (m, 2H), 3.44-3.40 (m, 2H), 3.34-3.29 (m, 1H), 3.07 (bs, 2H) OH, 2.54 (bs, 1H) OH, 
2.00 (s, 3H) COCH3,  0.95-0.89 (m, 21H) Si(CH(CH3)2).  LRMS (Ion Spray) exact mass 
calcd. for [M-H]- (C34H54NO12Si)- requires m/z 696.3, found m/z 696.9. 
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(9)  Compound 3 (5 mg, .005 mmol) was dissolved in methanol (0.127 mL) and to this was 
added acetic acid (1 μL).  Hydrogen was bubbled through the solvent for 1 minute and then 
palladium hydroxide (2 mg) was added.  The reaction was placed under 1 atmosphere of 
hydrogen and allowed to stir for 2 hours.  The reaction was then filtered over celite, diluted 
with ethyl acetate (5 mL) and washed once with a saturated aqueous sodium bicarbonate 
 solution (1 mL) and brine (1 mL).  The organic layer was dried with sodium sulfate, 
filtered, and concentrated via rotary evaporation.  The residue was purified via column 
chromatography (10-60% EtOAc/Hexane) to provide a 2.3:1 mixture of 9a and 9b.  1H 
NMR (300 MHz, CDCl3): 9a: δ = 7.99-7.94 (m, 2H) Ar-H, 7.52-7.30 (m, 3H) Ar-H, 5.86 
(m, 1H) CH2CHCH2O, 5.57 (bs, 1H),  5.37-5.12 (m, 3H), 5.09-4.91 (m, 2H), 4.86-4.70 (m, 
2H), 4.47-3.82 (m, 7H), 3.76 (s, 3H) CO2CH3, 3.72 (m, 1H), 3.39-3.30 (m, 2H), 2.01 (s, 
3H) COCH3, 1.95 (s, 3H) 1.93 (s, 3H) COCH3, 0.95-0.64 (m, 21H) Si(CH(CH3)2).  1H 
NMR (300 MHz, CDCl3): 9b: δ = 7.99-7.94 (m, 2H) Ar-H, 7.52-7.30 (m, 3H) Ar-H, 5.60 
(bs, 1H), 5.36 (m, 1H) 5.09-4.91 (m, 2H), 4.86-4.70 (m, 2H), 4.47-3.82 (m, 6H), 3.78 (s, 
3H) CO2CH3, 3.72 (m, 1H) 3.39-3.30 (m, 3H), 2.01 (s, 3H) COCH3, 1.95 (s, 3H) COCH3, 
1.93 (s, 3H) COCH3, 1.54-1.48 (m, 2H), 1.10-0.89 (m, 24H) Si(CH(CH3)2).  9a: LRMS 
(Ion Spray) exact mass calcd. for [M+Na]+ (C38H57NO15SiNa) requires m/z 818.3, found 
m/z 818.4. 9b: LRMS (Ion Spray) exact mass calcd. for [M+Na] (C38H59NO15SiNa) 
requires m/z 820.4, found m/z 820.5. 
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            (7)  Compound 10 (9 mg, 0.01 mmol) was dissolved in dimethylformamide (0.4 
mL), and sulfur trioxide trimethylamine complex (4.1 mg, 0.03 mmol) was added.  The 
reaction was heated to 60 °C and stirred for 7 hours.   Then, more sulfur trioxide 
trimethylamine complex was added (46 mg, 0.3 mmol), and the reaction was allowed to stir 
 for an additional 22 hours.  The reaction was cooled to room temperature.  Methanol (0.5 
mL) was added, and the reaction was stirred for 1 hour.  The reaction was concentrated via 
rotary evaporation and the residue loaded onto a Sephadex LH-20 column and eluted in 1:1 
dichloromethane/methanol to afford compound 10.  This compound was unable to be 
separated from residual sulfur trioxide trimethylamine salts.  1H NMR (500 MHz, CDCl3): 
δ = 7.95 (d, 2H, J = 7.0 Hz) Ar-H, 7.46-7.24 (m, 8H) Ar-H, 5.30 (dd, 1H, J = 9.0, 9.0 Hz) 
Glu H-3,  4.90 (d, 1H, J = 7.5 Hz) Glu H-5, 4.80 (d, 1H, J = 10.5 Hz) CH2Ph, 4.63-461 (m, 
2H) CH2Ph, Gal H-1, 4.46 (dd, 1H, J = 9.0, 8.0 Hz), Glu H-4, 4.31 (dd, 1H, J = 9.0, 8.5 
Hz) Glu H-2, 4.23-4.16 (m, 4H), 4.12 (bs, 1H) Gal H-4, 4.06 (d, 1H, J = 9 Hz) Glu H-1, 
3.71 (s, 3H) CO2CH3, 2.02 (s, 1H)COCH3, 0.95-0.89 (m, 21H) Si(CH(CH3)2).  Other peaks 
were masked by SO3TMA salts. LRMS (Ion Spray) exact mass calcd. for [M-H]- 
(C41H60NO19S2Si) requires m/z 962.3, found m/z 962.5. 
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 C h a p t e r  5  
Synthesis of a Second Differentially-Protected Chondroitin Sulfate Disaccharide and 
Its Elaboration to a Differentially-Protected Chondroitin Sulfate Tetrasaccharide 
Introduction  
            The construction of CS requires the stereospecific formation of β-(1,3)- and β-(1,4)-
glycosidic linkages.  These coupling reactions can be affected by many variables, including 
the protecting group scheme and the method of activation. The protecting group scheme 
can have two influences on the reaction.  First, the presence of a participating group or non-
participating group at the 2-position can affect the α:β ratio of the coupled products.  
Second, the protecting groups can deactivate the ring.  To that end, a variety of activation 
methods have been developed to improve the reactivity of the donor and to bias the coupled 
products towards a higher α or β ratio.1   
            The use of participating and non-participating protecting groups is the primary 
method employed by carbohydrate chemists to direct coupling reactions.  Participating 
groups are known to set a β-linkage.  They typically possess a carbonyl that adds into the 
anomeric position, forcing the acceptor to attack from the opposite face (Figure 5.1).   One 
drawback of using participating groups is that doing so can lead to the formation of 
undesired orthoester products.  
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Figure 5.1:  Participating groups can be used to direct the α:β ratio of coupling products.  
           Orthoesters are side products that result from the acceptor hydroxyl attacking the 
electrophilic carbon of the participating group instead of the anomeric position (Figure 5.2).  
While they are usually accessed inadvertently, stable orthoesters can also be formed 
intentionally and used to direct coupling reactions.  An orthoester will usually revert to a 
coupled saccharide when exposed to a Lewis acid.  In addition an orthoester will typically 
impart a stereochemical outcome on the coupled product.2 
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Figure 5.2:  Orthoesters are formed when the nucleophile attacks the participating group 
instead of the anomeric position. 
  
            While there are reported instances of glucosyl orthoesters leading to α-linked 
saccharides2, these orthoesters are usually considered to produce β-linkages.  Mechanistic 
studies suggest that orthoesters undergo a rearrangement that begins with cleavage of the 
C-O bond between the orthoester carbon and the eventual acceptor.  Then the released 
acceptor attacks the anomeric position of the donor to produce the desired disaccharide.  
For example, it is believed that disaccharide 4 is formed from orthoester 1 through the 
following pathway.  First, the orthoester C-O bond of saccharide 1 is cleaved to produce 
monosaccharides 2 and 3.   Acceptor 3 then attacks the anomeric position of donor 2 to 
produce the β-(1,3)-linkage of disaccharide 4  (Figure 5.3).1,3     
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Figure 5.3:  Proposed mechanism for orthoester rearrangement  
            It should also be noted that this reaction proceeds to selectively form the β-(1,3)-
linked disaccharide in 82% yield, despite the fact that the acceptor C-2 and C-4 hydroxyls 
are also available nucleophiles. Many orthoester rearrangements can be carried out on 
partially-deprotected substrates to provide the desired linkage if the desired hydroxyl is the 
 most reactive hydroxyl available on the acceptor.5 The primary hydroxyl (6-OH) is 
considered the most reactive position on the acceptor, and it usually follows that the 3-OH 
is more reactive than the 2-OH, which is more reactive than the 4-OH.   
            In addition to protecting groups participating in reactions to direct the α:β ratio of 
coupling reactions, protecting groups can also affect the reactivity of coupling partners.1,8  
For example, ester protecting groups are known to deactivate the ring.1  Even so, ester 
protecting groups are widely used in carbohydrate chemistry because they are stable in 
acidic conditions, able to be easily removed, and can serve as participating groups.1, 6  In 
addition, a C-5 methyl ester (such as the one on glucuronic acid) can also deactivate the 
ring.    To overcome the lowered reactivity, many methods have been developed to couple 
saccharides.  
            The classic glycosylation method is the Koenigs-Knorr reaction7, which refers to a 
substitution reaction of a glycosyl halide with the acceptor alcohol to produce the new 
saccharide (Figure 5.1).  Many other leaving groups have been introduced, such as the use 
of thioglycosides8 and phosphates.9  One of the most active leaving groups is the 
trichloroacetimidate.  Developed by Schmidt and coworkers,10 trichloroacetamides have 
been widely used in carbohydrate chemistry.  In CS chemistry, the trichloroacetimidate 
donor has been particularly helpful for setting the β-(1,4)-linkage between the 
galactosamine (GalNAc) and glucuronic acid (GlcA) moieties.11 
Progress Towards the Tetrasaccharide 
             To produce the donor and acceptor for the tetrasaccharide coupling, core 
disaccharide 5 was elaborated through the following steps.  We first removed the anomeric 
acetate with benzylamine in tetrahydrofuran and formed the imidate (as described in 
Chapter 3).  A portion of the imidate disaccharide was coupled to allyl alcohol to form 
disaccharide 7, and the C-4 TIPS group was removed with HF·pyridine (Scheme 5.1).  The 
resulting disaccharide (8) was combined with imidate donor 10 and TMSOTf, but instead 
of producing the desired tetrasaccharide, rearranged donor product 9 was formed, 
preventing the coupling of disaccharides 8 and 10 (Scheme 5.2).  This product most likely 
forms when the nucleophilic amine of the displaced trichloroacetimidate attacks the 
electrophilic anomeric position.   
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Scheme 5.1:  Elaboration of core disaccharide 5 to produce the disaccharide donor and 
acceptor 
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Scheme 5.2:  Attempts to couple disaccharides 8 and 10 resulted in a rearrangement to 
form disaccharide 9.    
 
            During the course of our laboratory’s synthesis of CS-E, a similar rearrangement 
product was observed.  In fact, it was thought that replacement of the trichloroacetyl (TCA) 
protecting group with a Troc protecting group would minimize this rearrangement because 
a more active donor would react faster with the acceptor.  However, studies performed by 
Dr. Song Gil Lee of both disaccharide 10 and 11 revealed that the TCA-protected donor 11 
was a superior coupling partner to disaccharide 11 (Figure 5.4).   
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Figure 5.4:  Model studies suggest that exchanging the Troc protecting group for a TCA 
protecting group minimizes rearrangement of the imidate.   
 
            Because of these results, we decided to change the amine protecting group from a 
Troc group to a TCA group.  To make core disaccharide 14, we synthesized acceptor 1312 
 and combined it with donor 12 in a TMSOTf-mediated coupling reaction at -10 oC.  
However, instead of producing disaccharide 14, orthoester 15 was produced as the main 
product (Scheme 5.3).     
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Scheme 5.3:  Donor 12 and acceptor 13 produce orthoester 15.  
 
            Knowing that orthoesters should be able to rearrange to form the desired 
disaccharide, we set out to find conditions that would permit this reaction.  First, we 
increased the amount of TMSOTf added to the reaction from 0.2 equivalents to 0.7 
equivalents and allowed the reaction to warm to room temperature.  This change increased 
the production of disaccharide 14.  Next we divided the TMSOTF into two additions, 
adding 0.4 equivalents of TMSOTf in the beginning and an additional 0.3 equivalents of 
TMSOTf after 5 hours.  Finally, we tried warming the reaction to 25 oC.  When these 
factors were combined, the desired disaccharide (14) was accessed in 52% yield.      
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Scheme 5.4:  Elaboration of core disaccharide 14 to common intermediate 16. 
            With this new core disaccharide, we needed to determine two things.  First, we 
needed to confirm that this disaccharide could still access the desired sulfation patterns.  To 
do so, disaccharide 14 was converted to common intermediate 16 through the following 
steps.  First, the anomeric acetate was removed with benzylamine in tetrahydrofuran.  Next, 
the resulting disaccharide was activated to the trichloroacetimidate donor and coupled to 
allyl alcohol to form disaccharide 15.  Finally, a radical conversion of the TCA group to the 
N-acetyl group produced disaccharide 16 (Scheme 5.4).   Second, we needed to confirm 
that it would also allow access to the desired tetrasaccharide.  Work by Dr. Song-Gil Lee 
has shown that disaccharide 14 can be elaborated to form tetrasaccharide 17 (Figure 5.5).12 
With these results, the syntheses of the core differentially-protected disaccharide and 
tetrasaccharide were complete.   
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Figure 5.5:  Core disaccharide 14 has been elaborated to tetrasaccharide 17. 
 
Conclusions 
         The choice of protecting groups can have a profound effect on glycosylation 
reactions.  When attempting to couple donor 8 and acceptor 10, a deleterious rearrangement 
of the donor occurred.  To minimize this rearrangement, the galactosamine C-2 amine 
protecting group was changed from a Troc protecting group to a TCA protecting group.  A 
new core disaccharide (14) was synthesized and elaborated to form disaccharide 16 which 
intersects the previous synthesis and has been used to form tetrasaccharide 17.   
  
Supporting Information 
 
General Methods 
 
Unless stated otherwise, reactions were performed in oven-dried  glassware that had 
been cooled in a desiccator over Dririte.  Reactions were performed under an argon 
environment unless otherwise stated.  All solvents were purified using the method of 
Grubbs.13 Unless stated otherwise, all commercially obtained reagents were used as 
received. Chemicals that were purified after purchase were purified according to the 
guidelines provided by Perrin and Armarego.14 Organic solutions were concentrated under 
reduced pressure on a Büchi rotary evaporator using an ice-water bath for volatile samples.  
High-performance liquid chromatography (HPLC) was performed on Hewlett-Packard 
1100 Series chromatographs using a Chiralcel OD-H column (25 cm) and OD-H guard (5 
cm) as noted.  Liquid chromatography mass spectrometry analysis was performed on an 
Aglient 1100 series LCMS using an acetonitrile/water mobile phase treated with 0.1% 
acetic acid with a quadrapole detector. Thin-layer chromatography (TLC) was performed 
using E. Merck silica gel 60 F254 precoated plates (0.25 mm). Visualization of the 
developed chromatogram was performed by fluorescence quenching, cerium ammonium 
molybdate stain, p-anisaldehyde stain, potassium permanganate stain, or ninhydrin stain, as 
necessary. Flash chromatography was performed on ICN silica gel (particle size 0.032 - 
0.063 mm) using the method of Still.15  
 1H NMR and proton decoupling spectra were recorded on a Varian Mercury 300 
(300 MHz),  a Varian Inova 500 (500 MHz), and Varian Mercury 600 (600 MHz) 
spectrometers and the 1H NMR spectra are reported in parts per million (δ) relative to the 
residual solvent peak. Data for 1H are reported as follows: chemical shift (δ, ppm), 
multiplicity (s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet), coupling constant(s) in Hz, and integration. 13C NMR spectra were obtained on 
a Varian Mercury 300 (75 MHz) spectrometer and 500 (125 MHz) and are reported in parts 
per million (δ) relative to the residual solvent peak. IR spectra were recorded on a Perkin 
Elmer Paragon 1000 spectrometer and are reported in terms of frequency of absorption 
(cm-1). A JASCO P-1010 was used to measure optical rotation. Mass spectra obtained from 
the Protein/Peptide MicroAnalytical Laboratory were generated on a Perkin Elmer/Sciex 
API 365 triple quadrapole mass spectrometer with nano spray ion source. Samples were 
dissolved in 50/50 MeOH/CH2Cl2, and infused at 0.2 microliter per minute.  High- 
resolution mass spectrometry was performed at the Mass Spectrometry Facility at the 
California Institute of Technology on either a JEOL JMS-600H High Resolution Mass 
Spectrometer or a UPLC-LCT Premier XT TOF Mass Spectrometer using Leu-Enkephalin 
as lock mass in order to obtain exact mass.  The UPLC-LCT Premier XT was purchased in 
2006 with a grant from the National Science Foundation Chemistry Research 
Instrumentation and Facilities Program (CHE-0541745). 
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(1)  To a solution of compound 2 (33 mg, 0.03 mmol) in THF (0.3 mL) was added 
benzylamine (0.01 mL, 0.1 mmol).  The solution was stirred for 7 hours, and the reaction 
was quenched by the addition of ethyl acetate (5 mL) and poured into an extraction funnel.  
The organic layer was washed with water (2x1 mL) and brine (1 mL) and dried over 
sodium sulfate.  The organic layer was filtered, and the solvent was removed via rotary 
evaporation.  The residue was purified via flash chromatography to afford compound 2 (22 
mg) in 74% yield as a white solid.  1H NMR (300 MHz, CDCl3): δ = 7.97 (d, 2H, J = 6.9 
Hz) ArH, 7.60 (t, 1H, J = 7.2 Hz) ArH, 7.49-7.33 (m, 7H) Ar-H, 6.36 (bs, 1H), 5.53 (bs, 
1H), 5.45 (m, 1H), 5.01-4.61 (m, 6H), 4.37 (bs, 1H),  4.28 (m, 1H), 4.20 (bs, 1H), 4.15-
3.81 (m, 5H), 3.48 (s, 3H) CO2CH3, 2.62 (bs, 1H) OH, 1.92 (s, 3H) C(O)CH3, 1.85 (s, 3H) 
C(O)CH3, 0.89-0.84 (m, 21H) CH(CH3)2.  13C NMR (75 MHz, CDCl3):  δ = 170.9, 170.1, 
164.6, 154.9, 138.1, 134.2, 130.2, 128.9, 128.9, 128.6, 128.1, 125.8, 94.2, 93.3, 92.4, 76.5, 
75.4, 74.9, 74.8, 74.7, 70.1, 69.1, 68.8, 68.6, 66.9, 63.9, 52.5, 21.4, 21.0, 18.1, 12.3.  LRMS 
(Ion Spray) exact mass calcd. for [M+Cl’]- (C43H58Cl4NO16Si) requires m/z 1012.2, found 
m/z 1012.1. 
 
 
 OHO
BnO
O
TrocHN
O
OAc
BzO
TIPSO
MeO2C
2
OAc
OAllylO
BnO
O
TrocHN
O
OAc
BzO
TIPSO
MeO2C
OAc
3
1. DBU, Cl3CCN, CH2Cl2
2. Allyl-OH, TMSOTf, CH2Cl2,
 
 
(3)   Compound 2 (194 mg, 0.2 mmol) was azeotroped three times with toluene and placed 
under vacuum for 8 hours before being added to a flame-dried flask with flame-activated 
4Å molecular sieves as a solution in dichloromethane (3.5 mL).  The reaction mixture was 
allowed to stir for 15 minutes before being cooled to 0 °C for the addition of freshly 
distilled 1,8-diazabicyclo[5.4.0]undec-7-ene (6 μL, 0.04 mmol) and freshly distilled 
trichloroacetonitrile (0.2 mL, 2 mmol).  The reaction was warmed to room temperature to 
stir for 6 hours.  Toluene (0.2 mL) was added to the reaction mixture which was 
concentrated before loading on a silica column pretreated with a mixture of 
hexane:toluene:ethyl acetate:triethylamine (50:20:20:1).  The column was eluted with a 
mixture of hexane:toluene:ethyl acetate (5:2:2) with triethylamine (0.1 mL), and the 
fractions containing the imidate were concentrated and kept under vacuum for 4 hours 
before being used in the next reaction.   (Rf = 0.5 in hexane:toluene:ethyl acetate (5:2:2) 
with 0.1 mL triethylamine, NOTE:  this compound is easily hydrolyzed so TLC plates must 
be pre-eluted with the hexane:toluene:ethyl acetate:triethylamine solution (50:20:20:1) 
before being spotted.) 
The imidate was added as a solution in dichloromethane (5 mL) to a flame-dried 
flask containing flame-activated 4Å molecular sieves.  Freshly distilled allyl alcohol (0.12 
mL, 1.75 mmol) was added, and the reaction mixture was stirred at room temperature for 
15 minutes before being cooled to -78  °C for the addition of trimethylsilyl triflate as a 
solution in dichloromethane (0.23 mL, 0.05 M).  The reaction was warmed to 0 °C and 
 stirred for 6 hours before being quenched by the addition of solution of pyridine in ethyl 
acetate (0.5 mL pyridine in 20 mL ethyl acetate).  The organic layer was washed with 
saturated aqueous sodium bicarbonate (10 mL) and brine (10 mL), and the organic layer 
was dried over sodium sulfate and filtered.  The solvent was removed via rotary 
evaporation, and the residue was purified via flash chromatography (hexane:toluene:ethyl 
acetate, 5:2:2) to afford compound 3 (122 mg) in 63% yield as a white solid.   (500 MHz, 
CDCl3): δ = 8.01 (dd, 2 H J = 1.5, 8.5 Hz) ArH, 7.96 (m, 1H) ArH, 7.46-7.29 (m, 7H) 
ArH, 5.87 (m, 1H) CH2CHCH2O, 5.38 (dd), 1H, J = 10.0, 10.0 Hz) Glu H-3, 5.28-5.24 (m, 
2H) CH2CHCH2O, NH; 5.18 (m, 1H) CH2CHCH2O, 5.10 (dd, 1H, J = 8.0, 8.0 Hz) Glu H-
4, 4.94 (m, 1H) Glu H-5,  4.89 (d, 1H, J = 29.0) CH2Ph, 4.85 (d, 1H, J = 29.0) CH2Ph, 4.80 
(m, 1H) Gal H-1, 4.71-4.64 (m, 2H) CH2CCl3, 4.53 (m, 1H) Gal H-3, 4.49 (dd, 1H, J = 8.5, 
8.5 Hz) Glu H-2, 4.36-4.31 (m, 2H) CH2CHCH2O, 4.12-4.05 (m, 3H) Glu H-1, 
CH2CHCH2O, Gal H-6; 4.04 (m, 2H) Gal H-4, Gal H-5, 3.81 (s, 3H) CO2CH3, 3.66 (m, 
1H) Gal H-6, 3.53 (m, 1H) Gal H-2, 1.94 (s, 3H) COCH3, 1.93 (s, 3H) COCH3, 0.97-0.85 
(m, 21H) Si(CH(CH3)2)3 13C NMR (125 MHz, CDCl3):  δ = 170.4, 169.4, 160.5, 154.2, 
137.9, 137.2, 133.7, 133.5, 129.6, 129.4, 128.6, 128.5, 128.4, 128.3, 128.2, 125.3, 117.8, 
95.6, 75.1, 74.6, 73.2, 73.0, 72.0, 70.9, 70.9, 70.0, 62.3, 52.5, 50.0, 20.7, 21.5, 20.9, 20.9, 
20.7, 17.9, 12.9.  LRMS (Ion Spray) exact mass calcd. for [M+Na]+ (C45H60Cl3NNaO17Si) 
requires m/z 1042.3, found m/z 1042.0. 
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 (4) Compound 3 (17 mg, 0.02 mmol) was dissolved in tetrahydrofuran (0.1 mL) and cooled 
to 0 oC.  To this solution was added 1.0 M TBAF in THF (25 μL) and acetic acid (2 μL), 
and the reaction was allowed to stir for 3 hours.  This reaction was diluted with ethyl 
acetate (2 mL), washed with saturated sodium bicarbonate (2 x 0.5 mL), water (0.5 mL), 
and brine (0.5 mL).  The organic layer was dried over sodium sulfate, filtered, and 
concentrated in vacuo.  The residue was purified via flash chromatography (30-70% 
EtOAc/Hexane) to afford compound 4 (6.8 mg, 0.01 mmol) in 47% yield.   (300 MHz, 
CDCl3): δ = 7.99 (m, 2 H) ArH, 7.60-7.24 (m, 8H) ArH, 6.05 (m, 1H), 5.82 (m, 1H) 
CH2CHCH2O, 5.48-5.45 (m, 1H), 5.33-5.10 (m, 4H), 4.91-4.74 (m, 4H), 4.67-4.61 (m, 
2H), 4.46 (d, 1H, J = 9.5 Hz), 4.37-4.25 (m, 2H), 4.21-4.12 (m, 2H), 4.09-3.97 (m, 3H), 
3.63 (s, 3H) CO2CH3, 3.15-3.10 (m, 1H), 2.30 (bs, 1H) OH, 1.94 (s, 3H) COCH3, 1.90 (s, 
3H) COCH3. LRMS (Ion Spray) exact mass calcd. for [M-H]- (C37H41Cl3NO16) requires 
m/z 860.1, found m/z 860.0. 
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(7)  Donor 5 (500 mg, 0.83 mmol) and acceptor 6 (434 mg, 0.87 mmol) were azeotroped 
three times with toluene and placed under vacuum overnight.  They were then dissolved in 
dichloromethane (2 mL) and added into a flame-dried vial containing dichloromethane (6 
mL) and activated 4 Ả molecular sieves.  This mixture was allowed to stir for 30 minutes.  
NIS (464 mg, 1.16 mmol) was added, and the reaction mixture was allowed to stir for an 
additional 15 minutes.  The reaction mixture was cooled to 0 oC and TMSOTf (1 M in 
dichloromethane, 0.4 mL) was added.  This reaction was quickly warmed to 25 oC and 
 allowed to stir for 5 hours, at which time more TMSOTf (1 M solution in dichloromethane, 
0.3 mL) was added.  The reaction mixture was allowed to stir for an additional 17 hours.  
Upon completion, the reaction was diluted with ethyl acetate (30 mL) and washed with 
saturated sodium bicarbonate (2 x 10 mL), water (10 mL), and brine (10 mL).  The organic 
layer was dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo.  The 
residue was purified via column chromatography (20-80% EtOAc/Hexane) to provide 
compound 7 (428 mg, 0.43 mmol) in 52% yield.  IR (film, CDCl3) 2946, 2867, 1751, 1731, 
1524, 1452, 1372, 1266, 1221, 1146, 1112, 1091, 1068, 1027, 1013 cm-1, 1H NMR (500 
MHz, CDCl3): δ = 8.04-8.02 (m, 2H) ArH, 7.70-7.35 (m, 8H) ArH, 6.75 (d, 1H, J = 8.5 
Hz) NH, 6.34 (d, 1H, J = 3.5 Hz) Gal H-1, 5.39 (dd, 1H, J = 8.0, 8.0 Hz) Glu H-3, 5.26 
(dd, 1H, J = 8.0, 9.0 Hz) Glu H-4, 5.09 (d, 1H, J = 8 Hz) Glu H-5, 5.03 (d, 1H, J = 11.0 Hz) 
CH2Ph, 4.77-4.72 (m, 1H) Gal H-2, 4.61 (d, 1H, J = 11.0 Hz) CH2Ph, 4.53 (dd, 1H, J = 8.0, 
8.0 Hz) Glu H-2, 4.31-4.28 (m, 1H) Gal H-3, 4.32 (d, 1H, J = 8.0 Hz) Glu H-1, 4.21-4.10 
(m, 3H) Gal H-5, Gal H-6, Gal H-6, 4.02 (bs, 1H) Gal H-4, 3.84 (s, 3H) CO2CH3,  2.23 (s, 
3H) C(O)CH3, 2.06 (s, 3H) C(O)CH3, 1.99 (s, 3H) C(O)CH3, 1.02-0.90 (m, 21H) 
CH(CH3)2.  13C NMR (500 MHz, CDCl3): δ = 176.7, 170.9, 170.1, 169.0, 168.5, 165.6, 
161.8, 137.9, 133.8, 132.7, 130.2, 129.9, 129.6, 128.7, 128.2, 100.3, 92.7, 91.2, 77.2, 75.4, 
75.2, 75.0, 74.8, 71.3, 71.1, 70.7, 62.8, 52.9, 50.2, 21.1, 21.0, 20.9, 18.2, 18.1, 18.1, 13.2.  
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(8) Compound 7 (67 mg, 0.07 mmol) was dissolved in tetrahydrofuran (0.4 mL), 
and to this was added benzylamine (40 μL).   This solution was allowed to stir for 7 hours.  
 The reaction was then diluted with ethyl acetate (3 mL) and washed with water (1 mL) and 
brine (1 mL).  The organic layer was dried over anhydrous sodium sulfate, filtered, and 
concentrated in vacuo.  The residue was purified via column chromatography to provide 
disaccharide 8 (46 mg, 0.05 mmol) in 73 % yield. 1H NMR (500 MHz, CDCl3): δ = 7.97-
7.95 (m, 2H) ArH, 7.58-7.30 (m, 8H) ArH, 6.83 (d, 1H, J = 9.5 Hz) NH, 5.34-5.30 (m, 2H) 
Gal H-1, Glu H-3, 5.16 (dd, 1H, J = 9.0, 9.0 Hz) Glu H-4, 5.01 (d, 1H, J = 11.0 Hz) CH2Ph, 
4.89 (d, 1H, J = 8 Hz) Glu H-5, 4.64-4.60 (m, 2H) CH2Ph, Gal H-2, 4.45 (dd, 1H, J = 8.5, 
8.5 Hz) Glu H-2, 4.20-4.04 (m, 5H) Gal H-3, Glu H-1, Gal H-5, Gal H-6, Gal H-6, 3.94 
(bs, 1H) Gal H-4, 3.80 (s, 3H) CO2CH3, 3.06, (bs, 1H) OH, 2.02 (s, 3H) C(O)CH3, 1.95 (s, 
3H) C(O)CH3, 0.96-0.92 (m, 21H) CH(CH3)2. 13C NMR (125 MHz, CDCl3): δ = 171.2, 
170.8, 167.0, 164.6, 157.7, 135.4, 134.1, 125.9, 125.6, 125.2, 124.7, 124.7, 124.2, 97.5, 
88.3, 88.0, 84.1, 71.6, 71.3, 71.2, 67.6, 67.3, 65.1, 59.7, 48.9, 47.2, 26.6, 16.9, 14.17, 9.3. 
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(9) Compound 8 (222 mg, 0.23 mmol) was azeotroped three times with toluene and placed 
under vacuum for 8 hours before being added to a flame-dried flask with flame-activated 
4Å molecular sieves as a solution in dichloromethane (5 mL).  The reaction mixture was 
allowed to stir for 15 minutes before being cooled to 0 °C for the addition of freshly 
distilled 1,8-diazabicyclo[5.4.0]undec-7-ene (7 μL, 0.05 mmol) and freshly distilled 
trichloroacetonitrile (0.23 mL, 2.3 mmol).  The reaction was warmed to room temperature 
to stir for 6 hours.  Toluene (0.2 mL) was added to the reaction mixture, which was 
 concentrated before loading on a silica column pretreated with a mixture of 
hexane:toluene:ethyl acetate:triethylamine (50:20:20:1).  The column was eluted with a 
mixture of hexane:toluene:ethyl acetate (5:2:2) with triethylamine (0.1 mL), and the 
fractions containing the imidate were concentrated and kept under vacuum for 4 hours 
before being used in the next reaction.   (Rf = 0.5 in hexane:toluene:ethyl acetate (5:2:2) 
with 0.1 mL triethylamine.   NOTE:  this compound is easily hydrolyzed so TLC plates 
must be pre-eluted with the hexane:toluene:ethyl acetate:triethylamine solution 
(50:20:20:1) before being spotted.) 
The imidate was added as a solution in dichloromethane (3 mL) to a flame-dried 
flask containing flame-activated 4Å molecular sieves.  Freshly distilled allyl alcohol (0.15 
mL, 2.22 mmol) was added, and the reaction mixture was stirred at room temperature for 
15 minutes before being cooled to -78  °C for the addition of trimethylsilyl triflate as a 
solution in dichloromethane (0.6 mL, 0.05 M).  The reaction was warmed to 0 °C and 
stirred for 6 hours before being quenched by the addition of solution of pyridine in ethyl 
acetate (30 mL, 3% pyridine in ethyl acetate).  The organic layer was washed with 
saturated aqueous sodium bicarbonate (10 mL) and brine (10 mL), and the organic layer 
was dried over sodium sulfate and filtered.  The solvent was removed via rotary 
evaporation, and the residue was purified via flash chromatography (hexane:toluene:ethyl 
acetate, 5:2:2) to afford compound 9 (136 mg, 0.14 mmol) in 59% yield as a white solid.   
1H NMR (500 MHz, CDCl3): δ = 7.96 (d, 2H, J = 7.5 Hz) ArH, 7.56-7.28 (m, 8H) ArH, 
7.07 (d, 1H, J = 7.0 Hz) NH, 5.86 (m, 1H) CH2CHCH2O, 5.32 (dd, 1H, J = 8.5, 8.5 Hz) 
Glu H-3, 5.26-5.23 (m, 1H) CH2CHCH2O, 5.19-5.17 (m, 1H) CH2CHCH2O, 5.12 (dd, 1H, 
J = 8.0, 8.5 Hz) Glu H-4, 4.97-4.90 (m, 3H) CH2Ph, Glu H-5, Gal H-1, 4.67 (d, 1H, J = 
 11.5 Hz) CH2Ph, 4.65-4.62 (m, 1H) Gal H-3, 4.47 (dd, 1H, J = 8.5, 8.5 Hz) Glu H-2, 4.34-
4.30 (m, 1H) CH2CHCH2O, 4.19-4.04 (m, 3H) Gal H-6, Glu H-1, CH2CHCH2O, 3.98-3.96 
(m, 2H) Gal H-4, Gal H-6, 3.76 (s, 3H) CO2CH3, 3.77-3.72 (m, 1H) Gal H-2, 3.70-3.67 (m, 
1H) Gal H-5, 2.06(s, 3H) C(O)CH3, 1.97(s, 3H) C(O)CH3,  0.96-0.85 (m, 21H) CH(CH3)2. 
13C NMR (125 MHz, CDCl3):  δ = 170.8, 169.9, 168.6, 165.7, 162.5, 133.6, 129.9, 129.4, 
128.7, 128.6, 128.1, 118.6, 101.4, 97.7, 88.3, 77.5, 75.4, 74.9, 74.8, 72.2, 71.0, 70.9, 70.5, 
63.1, 63.1, 52.7, 52.6, 21.1, 21.0, 18.1, 18.1, 13.1.  LRMS (Ion Spray) exact mass calcd. for 
[M+Na]+ (C45H60Cl3NNaO15Si) requires m/z 1010.3, found m/z 1010.2 
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(10) Disaccharide 9 (138 mg, 0.14 mmol) was dissolved in benzene (4.6 mL), and to this 
solution was added tributyltin hydride (0.22 mL, 0.83 mmol) and AIBN (44 mg).  The 
reaction was stirred at 80 oC under an argon atmosphere for 2 hours.  It was then cooled to 
room temperature, the solvent was removed via rotary evaporation, and the residue was 
purified via column chromatography (40-70% EtOAc/Hexane) to afford disaccharide 10 
(76 mg, 0.09 mmol) in 62% yield.  1H NMR (500 MHz, CDCl3): δ = 7.99 (d, 2H, J = 7.0 
Hz) Ar-H, 7.57 (t, 1H, J = 7.0 Hz) Ar-H, 7.44-7.28 (m, 7H) Ar-H, 5.87 (m, 1H) 
CH2CHCH2O, 5.63 (d, 1H, J = 7.0 Hz) NH, 5.38 (dd, 1H, J = 8.5, 8.5 Hz) Glu H-3, 5.24 
(m, 1H) CH2CHCH2O,  5.17 (m, 1H) CH2CHCH2O, 5.09 (dd, 1H, J = 8.0, 8.5 Hz) Glu H-
4, 4.98 (d, 1H, J = 8.5 Hz) Gal H-1, 4.90 (d, 1H, J = 12.5 Hz) CH2Ph, 4.88 (d, 1H, J = 8.5 
 Hz) Glu H-5, 4.74 (m, 1H) Gal H-3, 4.66 (d, 1H, J = 11.5 Hz) CH2Ph, 4.47 (dd, 1H, J = 
8.5, 8.5 Hz) Glu H-2, 4.14 (m, 1H) Gal H-6, 4.10 (d, 1H, J = 11.5 Hz) Glu H-1, 4.05 (m, 
2H) CH2CHCH2O, 3.91 (m, 1H) Gal H-5, 3.89 (m, 1H) Gal H-4, 3.77 (s, 3H) CO2CH3, 
3.66 (m, 1H) Gal H-6, 3.39 (m, 1H) Gal H-2, 2.00 (s, 3H) COCH3, 1.93 (s, 6H) COCH3, 
0.95-0.89 (m, 21H) Si(CH(CH3)2). 13C NMR (125 MHz, CDCl3):  δ = 171.3, 168.6, 165.8, 
138.4, 134.1, 133.6, 129.9, 129.6, 129.5, 128.7, 128.5, 127.9, 118.1, 101.8, 98.2, 78.2, 76.8, 
75.7, 72.7, 72.0, 71.1, 70.3, 63.3, 55.7, 52.7, 28.1, 27.1, 24.1, 20.9, 18.7, 18.2, 17.8, 13.9, 
13.2.  LRMS (Ion Spray) exact mass calcd. for [M+Na]+ (C45H63NNaO15Si) requires m/z 
908.4, found m/z 908.5. 
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